CN1117866C - 将预定改变引入有核细胞基因组的靶序列中的方法 - Google Patents

将预定改变引入有核细胞基因组的靶序列中的方法 Download PDF

Info

Publication number
CN1117866C
CN1117866C CN98118786A CN98118786A CN1117866C CN 1117866 C CN1117866 C CN 1117866C CN 98118786 A CN98118786 A CN 98118786A CN 98118786 A CN98118786 A CN 98118786A CN 1117866 C CN1117866 C CN 1117866C
Authority
CN
China
Prior art keywords
cell
chimeric
chimeric vector
target sequence
hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98118786A
Other languages
English (en)
Other versions
CN1215755A (zh
Inventor
E·B·克米克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of CN1215755A publication Critical patent/CN1215755A/zh
Application granted granted Critical
Publication of CN1117866C publication Critical patent/CN1117866C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明涉及将预定改变引入有核细胞基因组的靶序列的方法，该方法包括将一种嵌合载体保持在细胞核中，以便该嵌合载体与靶序列发生遗传学重组。其中该嵌合载体具有(i)至少一个连续未配对碱基区，使得未配对区将载体分成第一和第二链；(ii)两个靶序列同源区，和一个排列在两个同源区之间的编码所述改变的异源区，其中嵌合载体中的各同源区包含杂种双链部分。该方法可用来获得改变特征的细胞群。

Description

将预定改变引入有核细胞基因组的靶序列中的方法
本申请是申请号为94194935.4，申请日为1994年12月9日，发明名称为“用于真核细胞中定点突变的化合物”的发明专利申请的分案申请。
本申请是于1993年12月9日递交的第08/164303号专利申请的后续申请，后者全文引入本文以供参考。
1.发明领域
本发明涉及分子遗传学领域。具体地说它涉及向活的、培养的真核细胞中引入特定基因改变的核酸化合物及其应用。更具体地说，它主要涉及基本上沃森-克里克规则配对的双链核酸，其中双链中的一条链的部分包含含2′-O或2′-OMe核糖的核苷酸，剩余部分包含脱氧核糖核苷酸。
2.发明背景
2.1.嵌合和/或杂种双链核酸
本发明领域涉及核酸。核酸是杂聚物，即不同亚单位的聚合物，亚单位是通过定向的磷酸二酯键或其衍生物连接形成聚合物。双链核酸是这样的核酸，按照尿嘧啶或胸腺嘧啶与腺嘌呤对应和胞嘧啶与鸟嘌呤对应的原则，双链中第一链的每一碱基对应于第二链的碱基。据说拥有这种对应性的逆平行双链是沃森-克里克规则配对的。双链核酸可有两种主要类型：核糖核酸和脱氧核糖核酸。每种核糖核苷酸都有相应的脱氧核糖核苷酸，例如，腺嘌呤和脱氧腺嘌呤，胞嘧啶和脱氧胞嘧啶，鸟嘌呤和脱氧鸟嘌呤，尿嘧啶和胸腺嘧啶。如本领域中所用的那样，在同一链中存在核糖核苷酸和脱氧核糖核苷酸的核酸被称为混合或嵌合(下文称“嵌合”)核酸。其中脱氧核糖核苷酸和核糖核苷酸相互对应的双链核酸被称为杂种双链(hybrid-duplex)。当两条链形成少于其全部碱基的双链核酸区时，所形成的分子被称为异形双链(heteroduplex)。
更经常地，双链核酸的两条链是非共价键合的，而仅通过沃森-克里克规则配对相连。然而，双链的两条链可通过寡核苷酸连接形成单一聚合物(single polymer)。连接寡核苷酸不是沃森-克里克规则配对的。其中第一链和第二链是单一聚合物的部分的异形双链被称为“发夹双链”或“柱和环”结构。本文采用前一种名称。
本文所用嵌合现象是核酸聚合物的一种特性，而杂种现象则是双链的一种特性。例如，mRNA及其模板形成杂种双链，但二者都是非嵌合的，然而例如嵌合的八核苷酸5′d(TTTT)-r(CCCC)3′和5′r(GGGG)-d(AAAA)3′相互形成沃森-克里克规则双链，但生成的双链是非杂种双链。下文称非杂种双链的双链核酸为“同质双链”(homo-duplex)。除非另外特别说明，同质双链仅指包含脱氧核苷酸的双链。最后，值得注意的是本领域中称沃森-克里克规则双链的形成为“杂交(hybridigation)”，即使其形成的是非杂种双链核酸。
对X射线衍射和二维NMR分析嵌合和/或杂种核酸结构的研究感兴趣的人们已合成了用于此研究的嵌合核酸和杂种双链核酸。参见，例如Salazar，M.等，1994，J.Mol.Biol.241：440-55和EgIi，M.等，1993，Bioehemistry 32：3221-37(r3d7.d10形式的双链的嵌合杂种双链)；Ban，C.等，1994，J.Mol.Biol.236：275-85(d5r1d4形式的自身互补嵌合杂种双链)；Chou，S.H.，1991，Biochemistry 30：5248-57(d4r4d4形式的自身互补和非自身互补的嵌合杂种双链)。这些双链核酸的互补链彼此是非共价键合的；它们仅通过沃森-克里克规则配对相连。
合成了嵌合核酸的第二组科学家感兴趣于核糖酶(ribozyme)的研究和用途，核糖酶即自身切开或切开其它RNA的RNA分子.Perreault，J.P.等，1990，Nature 344：565；Taylor，N.R.等，1992，Neucleic Acids Research20：4559-65；Shimaya，T.，1993，Nrucleic Acids Research 21：2605。这些研究发现嵌合核糖酶具有活性，并且对核酸酶的消化比RNA核糖酶具有更强的耐受性。嵌合核糖酶是自身互补的，即沃森-克里克规则配对链是共价连接的。在嵌合核糖酶的研究期间合成的化合物不同于上面提到的杂种双链分子，它们被合成用于结构的研究，因为其中的嵌合核糖酶不包括稳定的杂种双链。因而，具有DNA结合臂的嵌合核糖酶与其底物结合，并形成杂种双链。Yang，G.H.等，1990，Biochemistry 29：11156-60。还参见Sawata，S.等，1993，Neucleic Acids Research 21：5656-60；Hendry，P.等，1992，Neucleic Acids Research 20：5737-41；Shimayama，T.，1993，Neucleic Acids Research 21：2605。核糖酶催化RNA底物的切开，杂种双链因此溶解。
2.2.真核细胞中定点遗传改变
分子生物学领域的技术人员知道不仅经常需要向靶真核细胞中引入新的多核酸序列，即新的基因，而且也需要对靶细胞中确定的预先存在的基因加以改变。靶细胞可在培养物中使用或者使用它建立转基因动物。
已经建立了许多向培养的真核细胞中引入DNA的技术。这些技术包括磷酸钙沉淀法，DEAE-葡聚糖介导的胞吞作用，电穿孔，脂质体介导的融合，使用复制缺损病毒的转导作用。然而，这些技术虽然十分普遍地用于向真核细胞中引入功能性基因，但它们不能轻而易举地完成对特定存在基因的改变(突变)。引入之后，外源性DNA通过异常重组在细胞基因组中随机位点上分离，而不是通过同源重组在特定位点上分离。
迄今为止，还没有一种令人普遍满意的向高级真核细胞，即哺乳动物或鸟类细胞中引入定点或特异位点的遗传改变(诱变)的方案。虽然在真核细胞中通过引入极长(＞1kb)的核酸可获得同源重组，但这些技术需要应用复杂的筛选技术，因为在高级真核细胞中异常重组率大大超过了同源重组率。Thomas，K.R.&Smithies，M.R.，1987，Cell 52：503。还参见Valancius，V.&Smithies，O.，1991，Mol.Cell.Biol.11：4389(比较真核细胞中线性化和超螺旋质粒的同源重组)。
一种完成优势定点诱变的方法是向细胞中直接引入单链寡脱氧核苷酸。这一技术被成功地用于酵母中，同源重组在啤酒酵母(Saccharomycescerevisiae)中的活性显著高于真核细胞。Moreschell，R.P.等，1988，Proc.Natl.Acad.Sci.85：524-28；Yamamoto，T.等，1992，Yeast 8：935-48。并且，至今也没有用单链寡核苷酸成功地转化哺乳动物或鸟类细胞的报道。
研究表明改变的嘌呤和嘧啶碱基区，即〔d(TG)30·d(AC)30〕显示显示了令人喜悦的重组率，由此可推知哺乳动物中靶DNA结构和同源重组率之间的关系。对培养的哺乳动物细胞的非复制质粒的研究证实了这些效果。Wahls，W.P.等，1990，Mol.Cell.Biol.10：785-93。这些实验没有进而表明外源性核酸和细胞基因组之间的重组。
曾尝试使用RecA，一种促进细菌(大肠杆菌)中同源重组的蛋白质来促进真核细胞中的同源重组。但是，这些尝试显然未获得成功。例如，W.Bertling的美国专利4950599公开了在真核细胞中使用RecA导致极低的定向位点突变率，并且同源重组率也未增高。D.Zarling和E.Sane的专利申请WO93/22443及D.C.Gruenert和Z.Kunzelmann的申请94/04032都旨在校正培养的涉及囊纤维变性的细胞系中的基因缺损。这些出版物公开了证实原理的原始实验数据而非涉及操作方法实施例的数据。为将多核苷酸/RecA复合物引入到核中，Zarling和Gruenert使用膜是通透性的细胞，尽管这类细胞不能进一步生长。另外，即使这些出版物宣称在完整细胞中发生了RecA促进同源重组，它们也未给出对其频率的定量评价。因此，还没有证据可令人信服地表明在任何活的真核细胞中，使用原核RecA导致的同源重组率明显高于自发性同源重组率。
3.发明概述
本发明涉及单一共价连接的双链寡核苷酸，它与所研究的基因同源，且具有脱氧核糖核苷酸和核糖核苷酸。为了产生遗传改变，在同源区内，有一对或多对非对应(下文称“异源”或“突变基因”)碱基对。通常，细胞原有的同源重组过程导致突变基因核苷酸插个靶基因组位置。可使用本发明的双链寡核苷酸(下文称“嵌合载体”)向基因中引入异源碱基对，特定地改变所研究的基因。异源碱基对可能是不同于所研究的基因的碱基对，或者可能是所研究基因中存在的碱基对之外那些碱基对(插入)，或者异源碱基对还可能是不存在于所研究基因中的碱基对(缺失)。本发明部分地是基于下述发现，即载体中包含杂种双链核酸的约15-50个碱基对区大大提高所研究基因的改变率。当异源碱基对区是1-50个碱基对时，异源碱基对可以同质或杂种双链存在于本发明的载体中。当异源碱基对长度大于50个碱基对时，它优选以同质双链存在。
可采用任何已知的向真核细胞中引入核酸的方法向靶细胞中引入载体。虽然就理论而言没有限定，但据信嵌合载体是通过靶细胞的重组/修复机制来参与的，并且经基因转化或同源重组指导靶基因改变。
4.附图的简要说明
图1显示图表表示的两种嵌合载体。特定标记如下：1，第一链；2，第二链；3，异源区；4，同质区；5，连接物；6，连接位点。
图1的符号图解
Figure C9811878600061
杂种双链(四聚物)同质双链(四聚物)
Figure C9811878600063
未配对的
图1A是R-D-R形式的连接的嵌合载体。
图1B是R-D-R形式的具有单一3′和5′末端的发夹式嵌合载体。
5.发明详述
5.1.本发明嵌合载体的描述
本发明包括含有含脱氧核糖和核糖的碱基双链核酸。因此它们包括DNA和RNA区，故而被称为“嵌合载体”。嵌合载体的核糖核苷酸的2′-O可以是甲基化的。任何磷酸二酯都可被硫代磷酸二酯或甲基磷酸二酯替代。
本发明的嵌合载体是单一核酸聚合物。因此本发明的嵌合载体须至少包括1个碱基至更通常的3或4个碱基，这些碱基不是沃森-克里克规则配对的。这些未配对碱基区连接两条沃森-克里克规则配对的碱基链。与其它合成的具有未配对核苷酸的嵌合核苷酸相反嵌合载体没有酶活性，即它们不催化化学反应或者在没有生物能源，如ATP存在下它们自身进行化学反应。
优选实施方案中的连接区碱基是脱氧核糖核苷酸。可构建具有两个连接区的嵌合载体，以使聚合物的3′和5′末端与相邻的互补链核苷酸呈沃森-克里克规则配对。它们易于连接使嵌合载体形成单一连续环状核酸聚合物。
基本上，嵌合载体的所有其余碱基都是沃森-克里克规则配对的。本文所描述的碱基是沃森-克里克规则配对的或它们形成双链核酸应被理解为在适当的温度和盐的条件下，它们可形成碱基对或双链核酸。应该知道在某些少盐和/或升高的温度条件下，沃森-克里克规则碱基对会失去热力学稳定性而使得双链核酸熔解掉或变性。还应知道一或两对碱基对失配并不影响本发明的可操作性。
本发明的嵌合载体旨在将改变(突变)特定地引入靶基因。通过选择具有与靶位点序列相同(同源)序列的嵌合载体部分(下文称之为同源区)确定遗传改变位点。嵌合载体序列和靶基因之间的不同区被称为异源区。应注意到嵌合载体与靶基因虽是异源的，但在该载体区中并不是异形双链。根据本发明的优选实施方案，每个嵌合载体有两个同源区，它们位于插入的异源区侧翼，所有这三个区都以单一连续双链核酸形式存在。再有，依据本发明，每个同源区包括杂种双链核酸部分。每个杂种双链至少是4对碱基对，优选为8对碱基对，更优选为约20-30对碱基对。嵌合载体的作用并不受到杂种双链区内同质双链的二核苷酸碱基对的影响，置入嵌合载体使3′和5′末端彼此连接。两个同源区的长度至少为20对碱基对，优选在40-60对碱基对之间。
依据本发明，可将同质双链核酸区排列在载体的杂种双链/同源区之间。被插入的同质双链区可包括异源区。当异源区少于约50对碱基对，优选地少于约20对碱基对时，可存在或不存在被插入的同质双链区。当异源区超过约20对碱基对时，包含异源区的被插入同质双链是优选的。
5.2.本发明的嵌合载体的构建
可使用任意方法合成本发明的嵌合载体。使用经改进的用于DNA固相合成的技术可最简便地合成嵌合载体。参见Caruthers，M.H.，1985，Science 230：281-85；Itakura，K.等，1984，Ann.Rev.Biochem.53：523-56。可合成RNA和嵌合核酸的改进方法公开于Searinge，S.A.等，1990，NucleicAcids Research 18：5433-41；Usman，N.等，1992，Nucleic Acids Research20：6695-99；和Swiderski，P.M.等，1994，Anal.Biochem.216：83-88，上述文献均全文引入本文以供参考。有关嵌合核酸合成的新近进展综述于Usman，N.&Cedergren，R.，1992，Trends Bioch.Sci.17：334-9。
插入两个杂种双链区之间的包含同质双链区的嵌合载体可使用半合成技术来建立。构建两种合成的具发夹构象的嵌合多聚核酸。使用与两种不同限制酶的消化产物的重叠部分互补的重叠交叉末端，构建两种嵌合核酸的游离3′和5′末端。得到与限制酶消化末端互补的同质双链区。可采用本领域技术人员熟知的技术来完成限制酶位点与克隆DNA片段末端的加成，所述技术例如，但不限于使用伸展引物的PCR扩增和包含限制位点的连接体的平整末端连接。可使用常规的酶促技术连接两种嵌合核苷酸和同质双链区。通过在Tris Borate EDTA缓冲液中的6％聚丙烯酰胺电泳从不完全反应的底物中分离两个末端连接的嵌合寡核苷酸。该线性加帽的分子是压缩的并且在这一条件下的电泳更缓慢。
仅含有天然产生的核苷酸的嵌合载体也可用于本发明。据发现包含约20个核糖核苷酸的杂种双链区的嵌合载体在体外是RNAse H抗性的。可通过用2′-O甲基化核糖核苷酸替代核糖核苷酸获得对酶促降解的抗性。另外或者可选择性地，核酸的磷酸二酯键可被硫代磷酸二酯键替代。Shimayama，T.等，1993，Nucleic Acids Research 21：2605.也可以使用含阿拉伯糖的核苷酸。本文所用术语核酸意指包括带有这些修饰的核酸。
5.3.本发明的嵌合载体的应用
本发明的嵌合载体可用于靶细胞基因组的特定位置上的突变。采用其核酸序列定义靶位的特定位置，下文中称此核酸序列为靶序。依据本发明构建嵌合载体，其中除存在某些杂种双链区外，同源区与靶序列一致。异源区编码被引入的变化。变化可是序列的一个或多个碱基变化或者是一个或多个碱基的加成。当靶序列的变化是少于约20个碱基的加成时，可采用一或二个杂种双链区实现本发明。当靶序列的变化是多于约50个碱基的加成时，则优选采用被包括在同质双链区内的异源区。
本发明的实现要求向靶细胞核中引入嵌合载体。任何导致这种引入的方法均可使用。这类方法包括电穿孔法，DEAE葡聚糖法，磷酸钙沉淀法，脂质体介导的融合法(LIPOFECTIN)和直接注射法。电穿孔法是特别适合的。
在本发明的一个实施方案中嵌合载体用于建立转基因动物。按照文献描述方法，采用直接注射法向卵细胞的原核中引入嵌合载体，所述文献是Brinster R.L.等，1989，PROC.NATL.ACAD.SCI.86：7087；还有T.E.Wagner和P.C.Hoppe的美国专利4,873,191，二者都全文引入本文以供参考。另外，可向胚胎干细胞中引入嵌合载体，可用正常胚泡细胞聚集胚胎干细胞从而产生嵌合动物，以嵌合动物的后代可重新获得转基因动物，该方法参见Capccchi，M.R.，1989，Science 244：1288，该文献全文引入本文以供参考。
采用电穿孔法，每10,000个被处理细胞就有一个细胞在靶序列上发生特异性突变(下文称“转化”)。因此，本发明的实践包括从大量未突变细胞中选择转化细胞的方法的使用。在另一个实施方案中，转化细胞的优点增多。这些增多的优点的非限制性实例包括抗药性，生长调节的改变和利用代谢物能力的改变。在另一个实施例中，选择方法是负选择法，使用该方法在所选择条件下使得被转化细胞不能生长，并且通过使其暴露在选择性破坏增殖细胞的条件下而除去未被转化的细胞。
另外，被转化的细胞可具有改变的细胞表面抗原表型，它可通过免疫荧光进行检测，采用荧光激活细胞分离器进行选择。
当向细胞中引入嵌合载体的方法是直接注射法时，例如当采用原核注射法建立转基因动物时，每10,000个细胞的转化率可高于1个细胞。因此，大大降低了选择的需要。
采用电穿孔法转化的嵌合载体的典型用量是每百万个培养细胞在10-1000ng之间。
6.实施例
6.1.实施例1：对黑粉菌属真菌的体内活性
野生型黑粉菌具有功能性的尿嘧啶(ura)-3基因，其产物是尿嘧啶生物合成途径中的一部分。当野生型黑粉菌生长于5′-fluororotic acid(5FOA)培养基中时，细胞由于该酸加入到上述途径中而死亡。假如尿嘧啶-3发生突变，则不会产生尿嘧啶-3mRNA，细胞就得以在5FOA培养基中存活。
内源性尿嘧啶-3基因序列是本领域中已知的。在一组实验中，该序列的碱基358由腺嘌呤变为胸腺嘧啶，这一突变导致功能障碍蛋白的产生。
嵌合载体的合成如下：
碱基358突变的载体：(358RNA载体)
5′TGCCGATCGGCAACTTTT GUUGCCGAUCGGCAAATTT 3′(SEQ ID：1)
该358载体采用发夹构象。划线碱基表示核糖核酸残基。黑体字母表示突变基因(异型区)。斜体″T″表示未配对碱基。
建立具有相同序列但不包含核糖核酸的载体作为对照。在该载体中胸腺嘧啶被尿嘧啶替代。
对照载体在碱基358进行突变：(DNA358载体)
5′TGCCGATCGGCAACTTTTGTTGCCGATCGGCAAATTT 3′
(SEQ ID：2)也采用发夹构象。再者，黑体残基是突变基因。
进行体内转化实验，按照本领域所熟知的方法，将U.maydis细胞制成回收率为50ul转化缓冲液中106个细胞的原生质体，并使用不同量的嵌合载体进行转染或者将同源(仅DNA)载体与原生质体在37℃混合。然后，将细胞铺于所选择的培养基上，计数存活菌落(转化细胞)的数目。结果以下面的表格形式表示：
    转染数量(ug)     载体-358类型     存活菌落数
    0.1     DNA     0
    0.1     嵌合的     13
    0.25     DNA     1
    0.25     嵌合的     49
    0.75     DNA     12
    0.75     嵌合的     131
    1.0     DNA     19
    1.0     嵌合的     573
这些数据表明使用RNA 358载体的细胞转染与使用相应DNA载体的转染相比，极大地提高了细胞的存活率。6.2.实施例2：NIH 3T3细胞的转化
NIH 3T3细胞是具有良性(可控制的)生长特性的人细胞。恶性(无控制的)生长特性是由致癌基因H→ras中的单位点突变给予的，所谓突变是由Thr替代Gly12。这样，G→T12导致生长特性的易于选择的变化。Taparowsky，E.等，1982，Nature 300：762；Sukumar S.等，1983，Nature306：658。
建立下述序列以指导发生G→T12突变的嵌合载体：5′-C ACACCGAC GGCGCCCACCACTTTGTGGTGGGCGCCGTCGGTGTGGGTTT GCC-3′(SEQ ID：3)
该序列以常规单字母代码表示，其它特点是未划线的表示RNA，未配对碱基是斜体，突变体碱基是黑体。需要注意的是，环化之后通过两个三胸腺嘧啶序列将嵌合载体分为两条基本上互补的链，并且所有含核糖的核苷酸仅存在于两条链中的一条。
使用2′-OMe核糖碱基合成两种形式的嵌合载体，它们分别具有一个(″R″)和两个(″R-D-R″)的翼侧有四个脱氧核糖残基的杂种双链区。R-D-R形式如上SEQ ID：3所示，R形式除碱基6-9是脱氧核苷酸外是相同的。值得注意的是，5′和3′末端是脱氧核苷酸。采用如在重组DNA中常用的相同DNA连接酶法，在合成之后环化嵌合载体。连接之后，通过两次重复的制备性D600凝胶(AT Biochem，Malvern，PA)电泳从底物中分离环化嵌合载体。
对照载体是：1)没有杂种双链的相同序列(“同质双链”
所示数据)；2)具有5′-GCCCACACCGACGGCGCCACCAC-3′(SEQ ID 4)序列的未配对DNA(“sDNA”所示数据)；3)没有异源区的嵌合载体，因而是没有突变基因的核苷酸(未显示数据)。
采用电穿孔法通过转化NIH 3T3细胞(1×106个细胞)进行实验。电穿孔法之后，将细胞以4×103个接种密度铺于培养基中并使其生长14天。用结晶紫染色灶形成细胞使转化细胞可见。使用编码T12形式的H ras的质粒pT24作为阳性对照。该对照用于测定转染的NIH 3T3细胞中的异常重组水平。该实验重复5次，下表表示其概括性结果。除下面所示结果外，使用没有突变基因密码子的嵌合载体的对照实验未显示出NIH 3T3细胞转化灶。
  载体类型     转染量(每106个细胞)     转化细胞每106个细胞(14天)
  pT24(阳性对照)     10ug     57
  sDNA     1ug     2
  sDNA     10ug     13
  同质双链     1ug     0
  同质双链     10ug     2
  嵌合的     50ng     R-D-R  R19     12
  嵌合的     200ng     55     43
  嵌合的     1ug     139    103
这些结果表明嵌合载体通过同源重组引入特定突变以转化哺乳动物细胞。该实验中的转化率大大高于通过异常重组的转化率，这是由使用包含完全突变的H-ras基因的pT24阳性对照载体进行转染观察到的。因此，在哺乳动物细胞中使用嵌合载体的同源重组率远远高于异常重组率。
                   序列表
(1)普通信息：
(i)申请者：Kmiec，Eric
(ii)发明题目：用于真核细胞中定点突变的化合物和方法
(iii)序列数：4
(iv)通讯地址：
(A)收信人：Pennie & Edmonds
(B)街道：1155 Avenue of the Americas
(C)城市：New York
(D)国家：NY
(F)邮政编码：10036-2731
(v)可读计算机源：
(A)媒介类型：软盘
(B)计算机：IBM PC兼容机
(C)操作系统：PC-DOS/MS-DOS
(D)软件：PatentIn Release #1.0，Version #1.25
(vi)当前申请资料：
(A)申请号：US
(B)递交日：
(C)分类：
(viii)律师/代理人信息：
(A)姓名：Friebel，Thomas E.
(B)注册号：29,258
(C)文献/摘要号：7991-009
(ix)通讯信息：
(A)电话：(212)790-9090
(B)传真：(212)869-8864/009   (2)第一序列(SEQ ID：1)信息：
(i)序列特征：
(A)长度：37对碱基对
(B)类型：核酸
(C)链合方式：自身互补
(D)拓扑结构：线性
(ii)分子类型：DNA/RNA
(ix)特点：
(A)名称/检索表：-
(B)位点：19..32
(D)其它信息：/标记＝a/注＝″RNA″
(xi)序列描述：第一序列描述：
TGCCGATCGG CAACTTTTGU UGCCGAUCGG CAAATTT          37(2)第二序列(SEQ ID：2)信息：
(i)序列特征：
(A)长度：37对碱基对
(B)类型：核酸
(C)链合方式：自身互补
(D)拓扑结构：线性
(ii)分子类型：DNA
(xi)序列描述：第二序列描述：
TGCCGATCGG CAACTTTTGT TGCCGATCGG CAAATTT           37(2)第三序列(SEQ ID：3)信息：
(i)序列特征：
(A)长度：53对碱基对
(B)类型：核酸
(C)链合方式：自身互补
(D)拓扑结构：线性
(ii)分子类型：DNA/RNA
(ix)特点：
(A)名称/检索表：-
(B)位点：2..5
(D)其它信息：/标记＝b/注＝″RNA″
(ix)特点：
(A)名称/检索表：
(B)位点：10..21
(D)其它信息：/标记＝d/注＝“RNA”
  (ix)特点：
(A)名称/检索表：
(B)位点：51..52
(D)其它信息：/标记＝f/注＝“RNA”
(xi)序列描述：第三序列描述：CACACCGACG GCGCCCACCA CTTTGTGGTG GGCGCCGTCG GTGTGGGTTT GCC         33(2)第四序列(SEQ ID：4)信息：
(i)序列特征：
(A)长度：23对碱基对
(B)类型：核酸
(C)链合方式：自身互补
(D)拓扑结构：线性
(ii)分子类型：DNA
(xi)序列描述：第四序列描述：GCCCACACCG ACGGCGCCAC CAC                   23

Claims (6)

1.一种将预定改变引入有核细胞基因组的靶序列中的方法，它包括下述步骤：
a.提供一种嵌合载体，它具有：
(i) 至少一个连续未配对碱基区，使得未配对区将载体分成第一和第二链；
(ii)两个靶序列同源区，和一个排列在两个同源区之间的编码所述改变的异源区，其中嵌合载体中的各同源区包含杂种双链部分；
b.使嵌合载体保持在细胞核中，以使嵌合载体与靶序列发生遗传学重组。
2.权利要求1的方法，其中核是卵的原核并且采用直接注射法引入改变。
3.权利要求1的方法，其中核是胚胎干细胞核并且采用直接注射法引入改变。
4.一种获得改变特征的细胞群的方法，它包括下述步骤：
a.提供一种嵌合载体，它具有：
(i) 至少一个连续未配对碱基区，使得未配对区将载体分成第一和第二链；
(ii)两个靶序列同源区，和一个排列在两个同源区之间的编码所述改变的异源区，其中嵌合载体中的各同源区包含杂种双链部分；
b.使嵌合载体保持在细胞核中，由此嵌合载体与靶序列发生重组，细胞被转化；及
c.选择转化细胞。
5.权利要求4的方法，其中细胞是哺乳动物细胞。
6.权利要求4的方法，其中细胞是酵母菌或真菌。
CN98118786A 1993-12-09 1998-08-22 将预定改变引入有核细胞基因组的靶序列中的方法 Expired - Fee Related CN1117866C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US164,303 1980-06-30
US16430393A 1993-12-09 1993-12-09
US164303 1993-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN94194935A Division CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物

Publications (2)

Publication Number Publication Date
CN1215755A CN1215755A (zh) 1999-05-05
CN1117866C true CN1117866C (zh) 2003-08-13

Family

ID=22593886

Family Applications (2)

Application Number Title Priority Date Filing Date
CN94194935A Expired - Fee Related CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物
CN98118786A Expired - Fee Related CN1117866C (zh) 1993-12-09 1998-08-22 将预定改变引入有核细胞基因组的靶序列中的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN94194935A Expired - Fee Related CN1048254C (zh) 1993-12-09 1994-12-09 用于将预定的改变引入靶基因中的化合物

Country Status (15)

Country Link
US (3) US5565350A (zh)
EP (1) EP0733059B1 (zh)
JP (1) JP3585238B2 (zh)
KR (1) KR100386337B1 (zh)
CN (2) CN1048254C (zh)
AT (1) ATE196311T1 (zh)
AU (1) AU691550B2 (zh)
CA (1) CA2178729A1 (zh)
DE (2) DE69425903T2 (zh)
DK (1) DK0733059T3 (zh)
ES (1) ES2149962T3 (zh)
GR (1) GR3034988T3 (zh)
NZ (1) NZ278490A (zh)
PT (1) PT733059E (zh)
WO (1) WO1995015972A1 (zh)

Families Citing this family (794)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739601B2 (en) * 1991-07-03 2001-10-18 Meditech Research Limited Use of hyaluronan in gene therapy
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US8153602B1 (en) 1991-11-19 2012-04-10 Isis Pharmaceuticals, Inc. Composition and methods for the pulmonary delivery of nucleic acids
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
US5523389A (en) * 1992-09-29 1996-06-04 Isis Pharmaceuticals, Inc. Inhibitors of human immunodeficiency virus
AU679566B2 (en) 1993-09-03 1997-07-03 Isis Pharmaceuticals, Inc. Amine-derivatized nucleosides and oligonucleosides
US6420549B1 (en) 1995-06-06 2002-07-16 Isis Pharmaceuticals, Inc. Oligonucleotide analogs having modified dimers
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US20030044941A1 (en) 1996-06-06 2003-03-06 Crooke Stanley T. Human RNase III and compositions and uses thereof
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
AU6659898A (en) * 1997-03-03 1998-09-22 Perkin-Elmer Corporation, The Improved chimeric oligonucleotide vectors
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6524613B1 (en) 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty
GB9711015D0 (en) * 1997-05-28 1997-07-23 Zeneca Ltd Improvements in or relating to organic compounds
JP2002510319A (ja) 1997-07-01 2002-04-02 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴヌクレオチドの消化管を介したデリバリーのための組成物及び方法
EP1007712A4 (en) * 1997-08-05 2004-06-30 Kimeragen Inc USE OF DUPLEX OLIGONUCLEOTIDES TO AFFECT LOCAL GENETIC CHANGES IN PLANTS
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
AU757672B2 (en) * 1997-11-18 2003-02-27 Pioneer Hi-Bred International, Inc. A method for directional stable transformation of eukaryotic cells
AU1526199A (en) 1997-11-18 1999-06-07 Pioneer Hi-Bred International, Inc. Targeted manipulation of herbicide-resistance genes in plants
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US6010907A (en) 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
WO1999060167A1 (en) 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (de) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
BR9914465A (pt) 1998-09-29 2001-10-09 Gamida Cell Ltd Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
AU773808B2 (en) 1998-11-09 2004-06-10 Bayer Cropscience Aktiengesellschaft Nucleic acid molecules from rice and their use for the production of modified starch
US6438561B1 (en) * 1998-11-19 2002-08-20 Navigation Technologies Corp. Method and system for using real-time traffic broadcasts with navigation systems
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU2415200A (en) * 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6917882B2 (en) * 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20030054390A1 (en) * 1999-01-19 2003-03-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
EP1108783A3 (en) * 1999-01-19 2001-09-05 Maxygen, Inc. Oligonucleotide-mediated nucleic acid recombination
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7024312B1 (en) * 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6127124A (en) * 1999-01-20 2000-10-03 Isis Pharmaceuticals, Inc. Fluorescence based nuclease assay
EP1165132B1 (en) * 1999-04-08 2011-10-19 Intercell USA, Inc. Dry formulation for transcutaneous immunization
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
EP1177299B1 (en) 1999-05-07 2008-10-29 E.I. Du Pont De Nemours And Company Auxin transport proteins
US6656730B1 (en) 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6271360B1 (en) * 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1218524A2 (en) * 1999-10-07 2002-07-03 Valigen Inc. Compositions and methods for plant genetic modification
AR025996A1 (es) * 1999-10-07 2002-12-26 Valigen Us Inc Plantas no transgenicas resistentes a los herbicidas.
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US7668658B2 (en) 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
US7253334B2 (en) 2000-12-22 2007-08-07 Aurox, Llc Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
WO2001035735A1 (en) * 1999-11-19 2001-05-25 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US20020055479A1 (en) 2000-01-18 2002-05-09 Cowsert Lex M. Antisense modulation of PTP1B expression
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US20060134629A1 (en) * 2000-03-20 2006-06-22 Link Charles J Methods and compositions for elucidating protein expression profiles in cells
US6897020B2 (en) * 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
US6936467B2 (en) * 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
AP2002002638A0 (en) * 2000-03-27 2002-09-30 Univ Delaware Targeted chromosomal genomic alternations with modified single stranded oligonucleotides.
AU2001263271A1 (en) * 2000-05-17 2001-11-26 University Of Delaware Plant gene targeting using oligonucleotides
US6686188B2 (en) 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) * 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
WO2001094610A2 (en) * 2000-06-05 2001-12-13 Thomas Jefferson University Binary hybrid mutational vectors
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
AU2001279069A1 (en) * 2000-07-27 2002-02-13 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
WO2002026967A2 (en) * 2000-09-25 2002-04-04 Thomas Jefferson University Targeted gene correction by single-stranded oligodeoxynucleotides
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2002303176A1 (en) * 2001-03-27 2002-10-15 University Of Delaware Genomics applications for modified oligonucleotides
WO2002081640A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene shinc-1 and diagnostic and therapeutic uses thereof
AU2002258728A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
WO2002081639A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US7053195B1 (en) * 2001-06-12 2006-05-30 Syngenta Participatious Ag Locked nucleic acid containing heteropolymers and related methods
DK2000545T3 (da) 2001-06-20 2011-11-28 Genentech Inc Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
AU2002315393A1 (en) 2001-06-21 2003-01-08 Isis Pharmaceuticals, Inc. Antisense modulation of superoxide dismutase 1, soluble expression
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US20030096772A1 (en) 2001-07-30 2003-05-22 Crooke Rosanne M. Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
AU2002326589B2 (en) * 2001-08-07 2008-06-05 University Of Delaware Compositions and methods for the prevention and treatment of Huntington's disease
US7227014B2 (en) 2001-08-07 2007-06-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein (a) expression
WO2003013226A2 (en) * 2001-08-09 2003-02-20 Cibus Genetics Non-transgenic herbicide resistant plants
US7456335B2 (en) * 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
NZ573740A (en) 2001-09-18 2010-07-30 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor, particularly kidney tumor - TAT184
US20070136825A1 (en) 2001-09-18 2007-06-14 Wolf-Bernd Frommer Fusion proteins useful for detecting analytes
EP1437936A4 (en) 2001-09-27 2005-10-12 Pioneer Hi Bred Int PHYTATE POLYNUCLEOTIDES AND METHOD FOR THEIR USE
EP1446503A2 (en) * 2001-09-27 2004-08-18 University Of Delaware Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
US20030207327A1 (en) * 2001-09-27 2003-11-06 Kmiec Eric B. Coisogenic eukaryotic cell collections
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
ATE516364T1 (de) 2001-10-09 2011-07-15 Isis Pharmaceuticals Inc Antisense-modulation der expression des insulinähnlicher-wachstumsfaktor-bindungsprotei s 5
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
AU2002367318B2 (en) 2002-01-02 2007-07-12 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en) 2002-01-25 2006-06-07 Gamida Cell Ltd PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
WO2003064621A2 (en) 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
EP2221377B2 (en) 2002-02-01 2017-05-17 Life Technologies Corporation Oligonucleotide compositions with enhanced efficiency
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US7135326B2 (en) * 2002-02-07 2006-11-14 E. I. Du Pont De Nemours And Company UDP-glucosyltransferases
WO2003069984A2 (en) * 2002-02-20 2003-08-28 American Integrated Biologics, Inc. Transgenic production in saliva
IL163875A0 (en) * 2002-03-07 2005-12-18 Univ Delaware Methods, compositions, and kits for enhancing oli gonucleotide mediated nucleic acid sequence alteration using compositions comprising a histone de
MXPA04009778A (es) 2002-04-08 2004-12-13 Pionner Hi Bred International Exsercion de fibra sedosa mejorada bajo estres.
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
AU2003230874A1 (en) 2002-04-16 2003-11-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2484676A1 (en) 2002-05-03 2003-11-13 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof, and related methods
EP1506289B1 (de) 2002-05-08 2012-08-08 BASF Plant Science GmbH Verfahren zum erhöhen des ölgehaltes in pflanzen
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
US20030228558A1 (en) * 2002-06-11 2003-12-11 Bloom William Dennis Method of training brokers in a multi-level marketing business
AU2003231912A1 (en) * 2002-06-12 2003-12-31 Tel Aviv Medical Center Research Development Fund Methods of detecting and treating prostate cancer
WO2004026343A1 (ja) * 2002-09-20 2004-04-01 Sumitomo Phamaceuticals Co., Ltd. 部位特異的遺伝子変換促進剤および遺伝子疾患治療剤
US7229976B2 (en) 2002-09-26 2007-06-12 Isis Pharmaceuticals, Inc. Modulation of forkhead box O1A expression
US20040175722A1 (en) * 2002-10-07 2004-09-09 Kmiec Eric B. Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
US9150605B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EP1560840B1 (en) 2002-11-05 2015-05-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EP1560839A4 (en) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION
US7429690B2 (en) * 2002-11-08 2008-09-30 Kirin Holdings Kabushiki Kaisha Transgenic bovines having reduced prion protein production
DK2336318T3 (da) 2002-11-13 2013-07-15 Genzyme Corp Antisense-modulering af apolipoprotein b-ekspression
JP4986109B2 (ja) 2002-11-13 2012-07-25 ジェンザイム・コーポレーション アポリポタンパク質ｂ発現のアンチセンス調節
CA2506127C (en) 2002-11-15 2013-07-09 Morphotek, Inc. Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
ATE405653T1 (de) 2002-12-19 2008-09-15 Bayer Cropscience Ag Pflanzenzellen und pflanzen, die eine stärke mit erhöhter endviskosität synthetisieren
CA2515484C (en) 2003-02-11 2011-09-20 Antisense Therapeutics Ltd Modulation of insulin like growth factor i receptor expression
BRPI0407514A (pt) 2003-02-17 2006-02-14 Metanomics Gmbh método para preparar um organismo não humano, polinucleotìdeo, método para preparar um vetor, vetor, célula hospedeira, polipeptìdeo, anticorpo, ácido polinucléico de anti-sentido, método para preparar uma planta, célula vegetal, tecido vegetal transgênicos, célula de um animal útil, animal útil ou um microorganismo transgênico organismo não humano, microorganismo transgênico, rendimento ou um material de propagação de uma planta ou de um animal útil, biomassa de um microorganismo, método para preparar produtos quìmicos finos, e, uso de polipeptìdeo
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
AU2004225838B2 (en) 2003-03-31 2009-11-05 University Of Bristol Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids
US20040205840A1 (en) * 2003-04-11 2004-10-14 Pioneer Hi-Bred International, Inc. Method for reducing gene expression
EP2361977A1 (en) 2003-04-15 2011-08-31 BASF Plant Science GmbH Nucleic acid sequences encoding proteins associated with abiotic stress response, and transgenic plant cells transformed with the same
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
CN1984921B (zh) 2003-06-03 2010-06-16 Isis药物公司 存活蛋白表达的调节
US7790691B2 (en) * 2003-06-20 2010-09-07 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation
WO2005013901A2 (en) 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
WO2005012316A2 (de) 2003-08-01 2005-02-10 Basf Plant Science Gmbh Verfahren zur herstellung mehrfach ungesättigter fettsäuren in transgenen
EP2434019A1 (en) 2003-08-01 2012-03-28 BASF Plant Science GmbH Process for the production of fine chemicals
DK1654276T3 (da) 2003-08-11 2013-04-08 Kweek En Researchbed Agrico Bv Svamperesistente planter og anvendelser af disse
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050053981A1 (en) 2003-09-09 2005-03-10 Swayze Eric E. Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
CA2538252C (en) 2003-09-18 2014-02-25 Isis Pharmaceuticals, Inc. 4'-thionucleosides and oligomeric compounds
NZ545134A (en) 2003-09-18 2009-06-26 Lilly Co Eli Modulation of eIF4E expression
NZ546272A (en) 2003-10-10 2009-05-31 Alchemia Oncology Pty Ltd The modulation of hyaluronan synthesis and degradation in the treatment of disease
EP2083089A1 (en) 2003-10-23 2009-07-29 Illumigen Biosciences, Inc. Detection of mutations in a gene associated with resistance to viral infection, oas1
US20050191653A1 (en) 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
ES2472690T3 (es) 2003-11-17 2014-07-02 Genentech, Inc. Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico
US20050120397A1 (en) * 2003-11-24 2005-06-02 Hermann Steller Compounds and methods for regulation of spermatid differentiation
ATE524551T1 (de) 2003-12-17 2011-09-15 Cropdesign Nv Pflanzen mit modifizierten wachstumseigenschaften sowie herstellungsverfahren dafür
WO2005062923A2 (en) * 2003-12-24 2005-07-14 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7608699B2 (en) * 2003-12-29 2009-10-27 Rockefeller University Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
EP2363480A3 (en) 2004-01-20 2015-10-07 Isis Pharmaceuticals, Inc. Modulation of glucocorticoid receptor expression
US7468431B2 (en) 2004-01-22 2008-12-23 Isis Pharmaceuticals, Inc. Modulation of eIF4E-BP2 expression
BRPI0508068B1 (pt) 2004-02-25 2017-11-28 Pioneer Hi-Bred International, Inc. Molecule of nucleic acid isolated, vector understanding, polyepeptide isolated, composition understanding the same and methods of transgenic plant production and increased insect resistance in transgenic plants
MXPA06009572A (es) 2004-02-27 2007-05-23 Basf Plant Science Gmbh Metodo para la produccion de acidos grasos poliinsaturados en plantas transgenicas.
WO2005083053A2 (de) 2004-02-27 2005-09-09 Basf Plant Science Gmbh Verfahren zur herstellung von ungesättigten omega-3-fettsäuren in transgenen organismen
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
EP1730309B1 (en) * 2004-03-15 2016-05-04 Ionis Pharmaceuticals, Inc. Compositions and methods for optimizing cleavage of rna by rnase h
WO2005094370A2 (en) 2004-03-29 2005-10-13 The General Hospital Corporation Oligonucleotide complex compositions and methods of use as gene alteration tools
US20050267300A1 (en) 2004-04-05 2005-12-01 Muthiah Manoharan Processes and reagents for oligonucleotide synthesis and purification
US20050244869A1 (en) 2004-04-05 2005-11-03 Brown-Driver Vickie L Modulation of transthyretin expression
US7420099B2 (en) * 2004-04-22 2008-09-02 Kirin Holdings Kabushiki Kaisha Transgenic animals and uses thereof
US20070072815A1 (en) * 2004-05-04 2007-03-29 Kmiec Eric B Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
US7825293B2 (en) 2004-05-28 2010-11-02 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
CA2734624A1 (en) 2004-06-09 2005-12-29 Pioneer Hi-Bred International, Inc. Plastid transit peptides
EP2080769A3 (en) 2004-07-02 2010-12-01 Metanomics GmbH Process for the production of fine chemicals
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
AU2005261646B2 (en) 2004-07-12 2012-02-02 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
EP1774004B1 (en) 2004-07-31 2013-07-10 Metanomics GmbH Preparation of organisms with faster growth and/or higher yield
PT2409713E (pt) 2004-08-10 2015-10-09 Genzyme Corp Oligonucleótidos para utilização em modulação dos níveis de lipoproteínas e colesterol em humanos
AU2005273864B2 (en) 2004-08-16 2010-09-30 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
JP2008513507A (ja) 2004-09-17 2008-05-01 アイシス ファーマシューティカルズ インコーポレイティッド 増強されたアンチセンスオリゴヌクレオチド
EP1794184A2 (en) 2004-09-24 2007-06-13 BASF Plant Science GmbH Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
DK1809302T3 (da) 2004-10-20 2012-11-26 Antisense Therapeutics Ltd Antisense-modulation af integrin-alfa-4-ekspression
CN101090972A (zh) 2004-10-29 2007-12-19 克罗普迪塞恩股份有限公司 具有改良生长特性的植物及其制备方法
AR051866A1 (es) 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
WO2006071219A1 (en) 2004-12-28 2006-07-06 Pioneer Hi-Bred International, Inc. Improved grain quality through altered expression of seed proteins
US8426683B2 (en) 2005-01-27 2013-04-23 Cropdesign N.V. Plants having increased yield and a method for making the same
WO2006091194A1 (en) 2005-02-23 2006-08-31 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
EP2573188A2 (en) 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
US8088971B2 (en) 2005-03-08 2012-01-03 Basf Plant Science Gmbh Expression enhancing intron sequences
KR20070110077A (ko) 2005-03-10 2007-11-15 제넨테크, 인크. 혈관 완전성을 조정하기 위한 방법 및 조성물
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1707632A1 (de) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US9085774B2 (en) 2005-04-19 2015-07-21 Basf Plant Science Gmbh Methods controlling gene expression
US8349991B2 (en) 2005-04-19 2013-01-08 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
US20060272057A1 (en) 2005-05-25 2006-11-30 Pioneer Hi-Bred International, Inc. Methods for improving crop plant architecture and yield
WO2007008300A2 (en) 2005-05-31 2007-01-18 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Triblock copolymers for cytoplasmic delivery of gene-based drugs
US8252756B2 (en) 2005-06-14 2012-08-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
CN101208432B (zh) 2005-06-23 2013-03-13 巴斯福植物科学有限公司 用于制备经稳定转化的、能育的玉米植物的改良方法
AU2006264937B2 (en) 2005-07-06 2011-01-27 Cropdesign N.V. Plant yield improvement by Ste20-like gene expression
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
BRPI0614367A2 (pt) 2005-08-12 2009-08-18 Basf Plant Science Gmbh célula de planta, planta, semente, molécula de ácido nucleico isolado, construto de ácido nucleico, vetor, célula hospedeira, proteìna relacionada a estresse isolada, métodos para produzir uma planta transgênica, para modificar toleráncia a estresse de uma planta, para detectar estresse ambiental em células de planta ou plantas, para triar células de planta ou plantas para toleráncia e/ou resistência aumentada a estresse ambiental, e para reproduzir células de planta ou plantas para toleráncia e/ou resistência aumentada a estresse ambiental, e, uso de um ácido nucleico
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
WO2007031581A2 (en) 2005-09-15 2007-03-22 Cropdesign N.V. Plant yield improvement by group 3 lea expression
EP1931789B1 (en) 2005-09-20 2016-05-04 BASF Plant Science GmbH Methods for controlling gene expression using ta-siran
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
US8853492B2 (en) 2005-11-07 2014-10-07 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
RU2008122542A (ru) 2005-11-07 2009-12-20 КРОПДИЗАЙН Н.Фи. (BE) Растения, характеризующиеся улучшенными ростовыми характеристиками, и способ их получения
AU2006311089C1 (en) 2005-11-08 2012-11-08 Basf Plant Science Gmbh Use of armadillo repeat (ARM1) polynucleotides for obtaining pathogen resistance in plants
WO2007054522A1 (en) 2005-11-08 2007-05-18 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US20070107084A1 (en) 2005-11-10 2007-05-10 Pioneer Hi-Bred International, Inc. Dof (DNA binding with one finger) sequences and methods of use
US20070199096A1 (en) 2005-11-14 2007-08-23 E.I. Du Pont De Nemours And Company Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content
EP1966377A2 (en) 2005-11-21 2008-09-10 Isis Pharmaceuticals, Inc. Modulation of eif4e-bp2 expression
US20090099075A1 (en) * 2005-11-24 2009-04-16 Basf Se Chimeric Keratin-Binding Effector Proteins
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US8487160B2 (en) 2005-12-01 2013-07-16 Cropdesign N.V. Plants having improved growth characteristics and methods for making the same
CN101341254A (zh) 2005-12-24 2009-01-07 蒂加斯克乳制品研究中心 反-10，顺-12十八碳二烯酸的生产方法
EP1976567B1 (en) 2005-12-28 2020-05-13 The Scripps Research Institute Natural antisense and non-coding rna transcripts as drug targets
US7592505B2 (en) 2005-12-30 2009-09-22 Pioneer Hi-Bred International, Inc. UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof
PT2465341E (pt) 2006-01-12 2015-03-09 Cibus Europe Bv Mutantes de epsps
CA2632872A1 (en) 2006-01-12 2007-07-19 Basf Plant Science Gmbh Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants
US7951934B2 (en) 2006-01-26 2011-05-31 Isis Pharmaceuticals, Inc. Compositions and their uses directed to huntingtin
JP5213723B2 (ja) 2006-01-27 2013-06-19 アイシス ファーマシューティカルズ， インコーポレーテッド マイクロｒｎａの調節に使用するためのオリゴマー化合物及び組成物
US7569686B1 (en) 2006-01-27 2009-08-04 Isis Pharmaceuticals, Inc. Compounds and methods for synthesis of bicyclic nucleic acid analogs
CA2640171C (en) 2006-01-27 2014-10-28 Isis Pharmaceuticals, Inc. 6-modified bicyclic nucleic acid analogs
CA2895745A1 (en) 2006-02-09 2007-08-16 Pioneer Hi-Bred International, Inc. Genes for enhancing nitrogen utilization efficiency in crop plants
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
EP2221382A3 (en) 2006-03-24 2010-12-01 BASF Plant Science GmbH Proteins associated with abiotic stress response and homologs
EP2199398A1 (en) 2006-03-31 2010-06-23 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
EP2090662A3 (en) 2006-04-05 2012-10-31 Metanomics GmbH Process for the production of a fine chemical
MX2008013354A (es) 2006-04-19 2008-11-10 Pioneer Hi Bred Int Moleculas de polinucleotidos aislados que corresponden a alelos mutantes y tipo salvaje del gen de maiz d9, y metodos para usarlas.
ES2471978T3 (es) 2006-05-05 2014-06-27 Isis Pharmaceuticals, Inc. Compuestos y procedimientos para modular la expresión de ApoB
WO2007134181A2 (en) 2006-05-11 2007-11-22 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
EP2410059A3 (en) 2006-05-30 2012-05-02 CropDesign N.V. Plants overexpressing Golden2-like protein (GLK) having enhanced yield-related traits and a method for making the same
EP2029619B1 (en) 2006-05-31 2013-01-09 Metanomics GmbH Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp)
EP2436761A1 (en) 2006-06-08 2012-04-04 BASF Plant Science GmbH Plants having improved growth characteristics and method for making the same
CA2654100A1 (en) 2006-06-15 2007-12-21 Cropdesign N.V. Use of nac transcription factor for enchancing yield-related traits in plants
CN105087634A (zh) 2006-06-15 2015-11-25 克罗普迪塞恩股份有限公司 具有增强的产量相关性状的nac转录因子受调节表达的植物和用于产生该植物的方法
RU2483057C2 (ru) 2006-06-28 2013-05-27 Ньюселис Инк. Смеси жирных кислот и их применение
AU2007363151B2 (en) * 2006-06-28 2014-12-11 Cibus Europe B.V. Alkylester fatty acid blends and uses therefor
WO2008011473A2 (en) 2006-07-19 2008-01-24 Isis Pharmaceuticals, Inc. Compositions and their uses directed to hbxip
ES2558133T3 (es) 2006-08-02 2016-02-02 Cropdesign N.V. Plantas transformadas con el polipéptido SYT que tienen el rendimiento aumentado en estrés abiótico y procedimiento de producción de las mismas
EP2199395A1 (en) 2006-08-02 2010-06-23 CropDesign N.V. Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same
WO2008025711A2 (de) 2006-08-30 2008-03-06 Basf Plant Science Gmbh Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
WO2008033375A2 (en) 2006-09-14 2008-03-20 Medgenics Ltd. Long lasting drug formulations
EP3066934A1 (de) 2006-10-06 2016-09-14 BASF Plant Science GmbH Verfahren zur herstellung mehrfach ungesättigter fettsäuren in transgenen organismen
CA2660861A1 (en) 2006-10-12 2008-04-17 Basf Plant Science Gmbh Method for increasing pathogen resistance in transgenic plants
WO2008043849A2 (en) 2006-10-13 2008-04-17 Basf Plant Science Gmbh Plants with increased yield
CA2660439C (en) 2006-10-24 2016-02-16 Basf Plant Science Gmbh Methods for increasing the resistance in plants to biotropic fungi
MX2009005160A (es) 2006-11-16 2009-05-28 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorados y un metodo para hacer las mismas usando secuencias de consenso de la familia de proteina y abby.
BRPI0718977A2 (pt) 2006-11-24 2014-02-04 Cropdesign Nv Método para aumentar rendimento de sementes em plantas em relação às plantas de controle, construção, uso da mesma, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica tendo redimento aumentado de sementes em relação às plantas de controle, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico
CA2671341A1 (en) 2006-12-15 2008-06-19 Cropdesign N.V. Plants having enhanced seed yield and method of making the same comprising expressing a class iii tpp polypeptide
MX2009005524A (es) 2006-12-21 2009-06-08 Basf Plant Science Gmbh Plantas con rasgos relacionados con un rendimiento mejorado y un metodo para producirlas.
EP1935428A1 (en) * 2006-12-22 2008-06-25 Antisense Pharma GmbH Oligonucleotide-polymer conjugates
US7872170B2 (en) 2006-12-28 2011-01-18 Pioneer Hi-Bred International, Inc. Genetic markers for orobanche resistance in sunflower
DK2617431T3 (en) * 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and applications therefor
EP2202314B1 (en) 2007-01-15 2014-03-12 BASF Plant Science GmbH Use of subtilisin (RNR9) polynucleotides for achieving a pathogen resistance in plants
WO2008092910A1 (en) 2007-01-30 2008-08-07 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
AR065121A1 (es) 2007-01-31 2009-05-20 Basf Plant Science Gmbh Plantas con rasgos aumentados relacionados con el rendimiento y/o resistencia incrementada al estres abiotico y un metodo para desarrollar las mismas
JP5512285B2 (ja) 2007-02-09 2014-06-04 ノースウェスタン ユニバーシティ 細胞内標的を検出するための粒子
DE112008000521T5 (de) 2007-02-28 2010-03-04 Cropdesign N.V. Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung
US8153863B2 (en) 2007-03-23 2012-04-10 New York University Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity
EP2570024A1 (en) 2007-04-04 2013-03-20 BASF Plant Science GmbH AHAS mutants
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
PL2144633T3 (pl) * 2007-04-23 2015-02-27 Sabag Rfa Ltd Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
EP2069509B1 (en) 2007-05-03 2013-09-18 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
DE112008001453T5 (de) 2007-05-22 2010-04-29 Basf Plant Science Gmbh Pflanzenzellen und Pflanzen mit erhöhter Toleranz und/oder Resistenz gegenüber Umweltstress und erhöhter Biomasseproduktion-KO
DE112008001452T5 (de) 2007-05-22 2010-12-16 Basf Plant Science Gmbh Pflanzen mit erhöhter Toleranz und/oder Resistenz gegen Umweltstress und erhöhter Biomasseproduktion
DE112008001326T5 (de) 2007-05-23 2010-07-01 Cropdesign N.V. Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung
WO2008145629A2 (en) 2007-05-25 2008-12-04 Cropdesign N.V. Yield enhancement in plants by modulation of maize alfins
EP2826863B1 (en) 2007-05-30 2017-08-23 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US8278425B2 (en) 2007-05-30 2012-10-02 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
EP2173760B2 (en) 2007-06-08 2015-11-04 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
CN102027120A (zh) 2007-06-29 2011-04-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
CA2692579C (en) 2007-07-05 2016-05-03 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
DE112008001879T5 (de) 2007-07-20 2010-07-29 Basf Plant Science Gmbh Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu irer Herstellung
KR101269930B1 (ko) 2007-07-31 2013-05-31 재단법인 작물유전체기능연구사업단 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
WO2009021137A2 (en) * 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
CN101821277B (zh) 2007-08-15 2014-05-07 Isis制药公司 四氢吡喃核酸类似物
MX2010002753A (es) 2007-09-14 2010-03-30 Basf Plant Science Gmbh Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas.
CN103695459A (zh) 2007-09-18 2014-04-02 巴斯夫植物科学有限公司 产量提高的植物
WO2009039442A1 (en) 2007-09-21 2009-03-26 California Institute Of Technology Nfia in glial fate determination, glioma therapy and astrocytoma treatment
EP2594646A3 (en) 2007-09-21 2013-11-06 BASF Plant Science GmbH Plant with increased yield
UA103176C2 (ru) 2007-09-21 2013-09-25 Басф Плант Саенс Гмбх Растение с повышенными показателями урожайности и способ его получения
US20100280098A1 (en) * 2007-10-05 2010-11-04 Juliano Rudolph L Receptor targeted oligonucleotides
EP2203565B1 (en) * 2007-10-05 2015-08-26 Cibus Europe B.V. Mutated acetohydroxyacid synthase genes in brassica
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
WO2009056566A2 (en) 2007-10-29 2009-05-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2009064771A2 (en) 2007-11-12 2009-05-22 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
WO2009064920A2 (en) 2007-11-13 2009-05-22 Isis Pharmaceuticals, Inc. Compounds and methods for modulating protein expression
US8916531B2 (en) 2007-11-20 2014-12-23 Isis Pharmaceuticals, Inc. Modulation of CD40 expression
BRPI0819743A2 (pt) 2007-11-20 2014-10-07 Pioneer Hi Bred Int Ácido nucléico isolado, cassete de expressão, célula hospedeira, planta transgênica, semente transgênica, método para modular a resposta de etileno em uma planta, proteína isolada
WO2009067647A1 (en) * 2007-11-21 2009-05-28 Isis Pharmaceuticals, Inc. Carbocyclic alpha-l-bicyclic nucleic acid analogs
US8704043B2 (en) 2007-11-22 2014-04-22 Cropdesign N.V. Plants having increased yield-related traits and a method for making the same
ES2553652T3 (es) 2007-11-26 2015-12-10 Basf Plant Science Gmbh Plantas que tienen rasgos potenciados relacionados con el rendimiento y un procedimiento de producción de las mismas
AR069893A1 (es) 2007-12-19 2010-02-24 Basf Plant Science Gmbh Plantas con mayor rendimiento y/o mayor tolerancia al estres ambiental (iy-bm)
US8575421B2 (en) 2007-12-20 2013-11-05 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
CN101952444A (zh) * 2007-12-21 2011-01-19 巴斯夫植物科学有限公司 产量提高的植物(ko nue)
EP2599874A3 (en) 2008-01-25 2013-11-13 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
AR070340A1 (es) 2008-01-31 2010-03-31 Nat Inst For Biolog Sciences Plantas que tienen crecimiento y/o desarrollo alterado mediante modulacion de la expresion de un acido nucleico que codifica una proteasa especifica de ubiquitina (ubp) proveniente de arabipdosis y oryza
EP2265627A2 (en) 2008-02-07 2010-12-29 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
BRPI0908093A2 (pt) 2008-02-27 2019-01-15 Basf Plant Science Gmbh núcleo de célula de planta transgênica, célula de planta transgênica, planta ou parte da mesma, molécula de ácido nucleico isolada, construto de ácido nucleico, vetor, núcleo hospedeiro ou célula hospedeira, anticorpo, tecido de planta, material de propagação, pólen, progênie, material colhido ou uma planta, processo para a identificação de um composto, composição, uso de uma molécula de ácido nucleico, processo para produzir um polipeptídeo, polipeptídeo, e, métodos para produzir uma planta transgênica ou uma parte da mesma, para produzir uma composição agrícola, para produzir um núcleo de célula de planta transgênica, uma célula de planta transgênica
WO2009117589A1 (en) 2008-03-21 2009-09-24 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising tricyclic nucleosides and methods for their use
DK2285819T3 (da) 2008-04-04 2013-12-02 Isis Pharmaceuticals Inc Oligomere forbindelser omfattende neutralt bundne, terminale bicykliske nukleosider
US9234205B2 (en) 2008-04-16 2016-01-12 Basf Plant Science Gmbh Method for increasing plant yield by expressing a nucleic acid encoding an ornithine decarboxylase polypeptide and plants expressing the same
WO2009135810A1 (en) 2008-05-05 2009-11-12 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
EP3260549A1 (en) * 2008-05-23 2017-12-27 Nucelis LLC Production of squalene using yeast
DE112009001459T5 (de) 2008-06-20 2011-09-29 Basf Plant Science Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
AU2009264386B2 (en) 2008-06-26 2015-09-10 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2297192A1 (en) 2008-07-04 2011-03-23 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein
US9175303B2 (en) 2008-07-17 2015-11-03 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
MX2011000778A (es) 2008-07-31 2011-03-15 Basf Plant Science Gmbh Plantas con caracteristicas modificadas de crecimiento y un metodo para obtenerlas.
US20110262485A1 (en) 2008-08-04 2011-10-27 University Of Miami Sting (stimulator of interferon genes), a regulator of innate immune responses
EP2352822A2 (en) 2008-08-19 2011-08-10 BASF Plant Science GmbH Plants with increased yield by increasing or generating one or more activities in a plant or a part thereof
AU2009284263B2 (en) 2008-08-20 2015-04-09 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
DK2331141T3 (en) 2008-08-25 2016-04-04 Excaliard Pharmaceuticals Inc Antisense oligonucleotides WHO IS TARGETING connective tissue, AND USES THEREOF
BRPI0913477A2 (pt) 2008-09-11 2015-07-28 Keygene Nv "método para desenvolvimento de marcador diagnóstico"
CA2736473A1 (en) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Plants with increased yield (lt)
DK2356129T3 (da) 2008-09-24 2013-05-13 Isis Pharmaceuticals Inc Substituerede alpha-L-bicykliske nukleosider
EP2334797A1 (en) 2008-09-24 2011-06-22 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
US8604192B2 (en) 2008-09-24 2013-12-10 Isis Pharmaceuticals, Inc. Cyclohexenyl nucleic acids analogs
PL2342331T3 (pl) 2008-09-26 2016-05-31 Basf Agrochemical Products Bv Mutanty ahas odporne na herbicydy i sposoby ich zastosowania
JP5809058B2 (ja) 2008-10-15 2015-11-10 アイシス ファーマシューティカルズ， インコーポレーテッド 第１１因子発現の調節
KR20170001756A (ko) * 2008-10-20 2017-01-04 모레 매트릭스 인코포레이티드 유착 치료 또는 예방용 폴리펩티드
AR075466A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas tipo auxina en plantas cultivadas
AR075465A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas de sulfonilurea en plantas cultivadas
EP2350289A1 (en) 2008-10-23 2011-08-03 BASF Plant Science GmbH Plants with increased yield (nue)
EP2350287A2 (en) 2008-10-23 2011-08-03 BASF Plant Science GmbH A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content
CN102264374B (zh) 2008-10-24 2015-01-07 Isis制药公司 5′和2′双取代的核苷和由其制备的低聚化合物
EP2358398A2 (en) 2008-10-24 2011-08-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
EP2184351A1 (en) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynucleotides encoding caryophyllene synthase and uses thereof
CN102197137A (zh) 2008-10-30 2011-09-21 先锋国际良种公司 对谷氨酰胺合成酶(gs)进行操作以改善高等植物中的氮利用效率和籽粒产量
AU2009315732A1 (en) 2008-11-12 2010-05-20 Basf Plant Science Gmbh Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
BRPI0823236A2 (pt) 2008-11-14 2015-06-16 Fujian Fuda Biotech Co Ltd Fitase termotolerante de escherichia coli não-k12 e sua produção.
WO2010060110A1 (en) 2008-11-24 2010-05-27 Northwestern University Polyvalent rna-nanoparticle compositions
CN104328137A (zh) 2008-12-03 2015-02-04 巴斯夫植物科学有限公司 具有增强的非生物胁迫耐受性和/或增强的产量相关性状的植物及其制备方法
US8921329B2 (en) 2008-12-04 2014-12-30 Curna, Inc. Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
US20110237649A1 (en) 2008-12-04 2011-09-29 Opko Curna, Llc Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
US8431775B2 (en) 2008-12-04 2013-04-30 Pioneer Hi Bred International Inc Methods and compositions for enhanced yield by targeted expression of knotted1
US20110294870A1 (en) 2008-12-04 2011-12-01 Opko Curna, Llc Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
US9327008B2 (en) 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
DE112009003708T5 (de) 2008-12-12 2012-09-13 Basf Plant Science Gmbh Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenenOrganismen
CA2745747A1 (en) 2008-12-17 2010-06-24 Basf Plant Science Gmbh Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same
EP2376633A1 (en) 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP2204086A1 (en) 2009-01-02 2010-07-07 Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) Six row-type barley
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
JP2012515214A (ja) 2009-01-14 2012-07-05 トヘ サルク インストイトウテ フオル ビオルオギクアル ストウドイエス スクリーニング方法、及びアミロイド病に対し保護する化合物
CN102365366A (zh) 2009-01-28 2012-02-29 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
WO2010091308A2 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
KR101805199B1 (ko) 2009-02-12 2017-12-05 큐알엔에이, 인크. 신경교세포 유래된 신경영양성 인자 (ｇｄｎｆ)에 대한 자연 안티센스 전사체의 저해에 의한 신경교세포 유래된 신경영양성 인자 (ｇｄｎｆ) 관련된 질환의 치료
DK2396038T3 (en) 2009-02-12 2016-02-01 Curna Inc TREATMENT OF BRAIN-DERIVATED NEUROTROPHIC FACTOR- (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTION TO BDNF
DE112010000887T5 (de) 2009-02-25 2012-09-27 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
US8716553B2 (en) 2009-03-02 2014-05-06 Pioneer Hi Bred International Inc NAC transcriptional activators involved in abiotic stress tolerance
WO2010102058A2 (en) 2009-03-04 2010-09-10 Curna, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
EP2408919B1 (en) 2009-03-16 2017-10-18 CuRNA, Inc. Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
EP2408920B1 (en) 2009-03-17 2017-03-08 CuRNA, Inc. Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
UA108071C2 (uk) 2009-04-14 2015-03-25 Піонер Хай-Бред Інтернешнл, Інк. Спосіб поліпшення витривалості до нестачі азоту у рослини
DE112010001705T5 (de) 2009-04-21 2013-01-24 Basf Plant Science Company Gmbh RNA-vermittelte lnduktion von Genexpression in Pflanzen
DE112010001703T5 (de) 2009-04-21 2012-09-20 Basf Plant Science Company Gmbh RNA-vermittelte Induktion von Genexpression in Pflanzen
EP3524275A1 (en) 2009-04-22 2019-08-14 Massachusetts Institute Of Technology Innate immune supression enables repeated delivery of long rna molecules
BRPI1014386A2 (pt) 2009-04-29 2015-08-25 Basf Plant Science Co Gmbh Métodos para intensificar traços relacionados com o rendimento em plantas com relação às plantas de controle, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, partes colhíveis de uma planta, produtos, uso de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo.
MX2011011453A (es) 2009-04-29 2011-11-18 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
ES2661787T3 (es) 2009-05-01 2018-04-04 Curna, Inc. Tratamiento de enfermedades relacionadas con hemoglobina (hbf/hbg) por inhibición de transcrito antisentido natural para hbf/hbg
WO2010129501A1 (en) 2009-05-04 2010-11-11 Pioneer Hi-Bred International, Inc. Yield enhancement in plants by modulation of ap2 transcription factor
WO2010129746A2 (en) 2009-05-06 2010-11-11 Curna, Inc. Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
DE112010002275T5 (de) 2009-05-06 2013-06-20 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und/oder gesteigerter Toleranz gegenüberabiotischem Stress und Verfahren zu deren Herstellung
WO2010129799A2 (en) 2009-05-06 2010-11-11 Curna, Inc. Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
DK2432881T3 (en) 2009-05-18 2018-02-26 Curna Inc TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
WO2010135695A2 (en) 2009-05-22 2010-11-25 Curna, Inc. TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
US8791085B2 (en) 2009-05-28 2014-07-29 Curna, Inc. Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
EP2443237B1 (en) 2009-06-16 2017-02-22 CuRNA, Inc. Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
KR101702689B1 (ko) 2009-06-16 2017-02-06 큐알엔에이, 인크. Ｐｏｎ1에 대한 천연 안티센스 전사체의 억제에 의한 파라옥소나제 1(ｐｏｎ1) 관련된 질환의 치료
CN102656270B (zh) 2009-06-19 2015-05-13 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
WO2010151671A2 (en) 2009-06-24 2010-12-29 Curna, Inc. Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
EP2446037B1 (en) 2009-06-26 2016-04-20 CuRNA, Inc. Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
US20120174261A1 (en) 2009-06-30 2012-07-05 E. I. Du Pont De Nemours And Company Plant seeds with alterred storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase
EP2272862B1 (en) 2009-07-10 2012-03-21 Freie Universität Berlin Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors AHK2 and AHK3
EP2275564A1 (en) 2009-07-17 2011-01-19 Freie Universität Berlin Means and method for the production of transgenic plants that are resistant to clubroot
US20120117867A1 (en) 2009-07-23 2012-05-17 Basf Plant Science Company Gmbh Plants with Increased Yield
US9175301B2 (en) 2009-07-24 2015-11-03 Pioneer Hi Bred International Inc Use of dimerization domain component stacks to modulate plant architecture
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
WO2011017516A2 (en) 2009-08-05 2011-02-10 Curna, Inc. Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
US20110035843A1 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
WO2011017521A2 (en) 2009-08-06 2011-02-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexose nucleic acid analogs
GB0914012D0 (en) 2009-08-11 2009-09-16 Plant Bioscience Ltd Stress tolerant plants
US20120144529A1 (en) 2009-08-19 2012-06-07 Basf Plant Science Company Gmbh Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
BR112012003761A2 (pt) 2009-08-20 2015-09-08 Pionner Hi Bred International Inc polinucleotideo transportador de nitrato, vetor, cassete de expressao, celula hospedeira, planta transgenica, semente, metodo para aumentar a produtividade em uma planta, metodo de modulacao do nivel de proteina nt em uma celula de planta e em uma planta, metodo de modulacao de absorcao de nitrato em plantas, metodo de desacoplamento em um nitrato de planta que sinaliza a absorcao de nitrato, polinucleotideo de nitrato redutase (nr) recombinante ou isolado.
CA2771172C (en) 2009-08-25 2021-11-30 Opko Curna, Llc Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
CN112011566B (zh) 2009-08-31 2023-12-05 巴斯夫植物科学有限公司 用于在植物中增强种子特异性基因表达而促进增强的多不饱和脂肪酸合成的调节性核酸分子
WO2011023539A1 (en) 2009-08-31 2011-03-03 Basf Plant Science Company Gmbh Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants
KR20120092104A (ko) 2009-08-31 2012-08-20 바스프 플랜트 사이언스 컴퍼니 게엠베하 식물에서 구성적 유전자 발현을 향상시키기 위한 조절 핵산 분자
US9321823B2 (en) 2009-09-02 2016-04-26 Genentech, Inc. Mutant smoothened and methods of using the same
MX2012003451A (es) 2009-09-25 2012-05-22 Basf Plant Science Co Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para prepararlas.
WO2011036232A1 (en) 2009-09-25 2011-03-31 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
BR112012007516A2 (pt) 2009-10-02 2015-09-15 Pioneer Hi Bred Int ácido nucléico isolado, plantas , células vegetais, métodos de redução de produção de etileno em uma planta, de aumento de produtividade em uma planta e de aumento de tolerância à aridez, cassete de expressão e semente
CN102666858A (zh) 2009-10-22 2012-09-12 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
MX2012004617A (es) 2009-10-22 2012-05-08 Genentech Inc Metodos y composiciones para modular activacion de hepsina de proteina que estimula macrofago.
AR078829A1 (es) 2009-10-30 2011-12-07 Du Pont Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico
KR20120136345A (ko) 2009-10-30 2012-12-18 노오쓰웨스턴 유니버시티 주형화된 나노컨쥬게이트
CA2779830C (en) 2009-11-13 2020-07-21 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
CN104651323A (zh) 2009-11-13 2015-05-27 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
CA2780707A1 (en) 2009-11-17 2011-05-26 Basf Plant Science Company Gmbh Plants with increased yield
JP5978132B2 (ja) 2009-11-23 2016-08-24 ニューセリス インコーポレイテッド 酵母を用いるスクアレン生成のための方法および組成物
MX338694B (es) 2009-11-30 2016-04-27 Genentech Inc Composiciones y metodos para el diagnostico y el tratamiento de tumores.
JP6025567B2 (ja) 2009-12-16 2016-11-16 カッパーアールエヌエー，インコーポレイテッド 膜結合転写因子ペプチダーゼ、部位１（ｍｂｔｐｓ１）に対する天然アンチセンス転写物の阻害によるｍｂｔｐｓ１関連性疾患の治療
EP2516648B1 (en) 2009-12-23 2017-11-08 CuRNA, Inc. Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
JP6031356B2 (ja) 2009-12-23 2016-11-24 カッパーアールエヌエー，インコーポレイテッド Ｕｃｐ２に対する天然アンチセンス転写産物の阻害による脱共役タンパク質２（ｕｃｐ２）関連疾患の治療
CA2784148A1 (en) 2009-12-28 2011-07-28 Pioneer Hi-Bred International, Inc. Sorghum fertility restorer genotypes and methods of marker-assisted selection
KR101853508B1 (ko) 2009-12-29 2018-06-20 큐알엔에이, 인크. 종양 단백질 63 (ｐ63)에 대한 천연 안티센스 전사체의 억제에 의한 ｐ63에 관련된 질환의 치료
CA2785173A1 (en) 2009-12-29 2011-07-28 Curna, Inc. Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
CA2786001A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
NO2521784T3 (zh) 2010-01-04 2018-05-05
CN102822342B (zh) 2010-01-06 2017-05-10 库尔纳公司 通过抑制胰腺发育基因的天然反义转录物而治疗胰腺发育基因相关疾病
WO2011085062A1 (en) 2010-01-06 2011-07-14 Pioneer Hi-Bred International, Inc. Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants
WO2011085102A1 (en) 2010-01-11 2011-07-14 Isis Pharmaceuticals, Inc. Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
US9200277B2 (en) 2010-01-11 2015-12-01 Curna, Inc. Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
WO2011091244A1 (en) 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
US8946182B2 (en) 2010-01-25 2015-02-03 Curna, Inc. Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
CA2818599A1 (en) 2010-01-26 2011-08-04 Bailin Li Polynucleotide and polypeptide sequences associated with herbicide tolerance
EP2539452B1 (en) 2010-02-22 2016-07-27 CuRNA, Inc. Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
PE20130214A1 (es) 2010-02-23 2013-03-11 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
WO2011105901A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 9 (c9) and uses thereof
WO2011105900A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
WO2011105902A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-beta (c8-beta) and uses thereof
CA2788241A1 (en) 2010-02-24 2011-09-01 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
BR112012021232A2 (pt) 2010-02-24 2015-09-08 Basf Plant Science Co Gmbh método para acentuar traços relacionados a rendimento em plantas, plantas, construções, usos de uma construção. métodos de produção de uma planta transgênica, planta transgênicas, partes colhíveis de uma planta, produtos derivados de uma planta, uso de um a´cido nuclleíco
EP2361985A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2361927A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
WO2011109618A2 (en) 2010-03-03 2011-09-09 E. I. Du Pont De Nemours And Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding oxidoreductase motif polypeptides
GB201003702D0 (en) 2010-03-05 2010-04-21 Univ Warwick Molecular engineering of a floral inducer for crop improvement
EP2544703A4 (en) 2010-03-12 2013-09-18 Brigham & Womens Hospital METHODS OF TREATING VASCULAR INFLAMMATORY DISORDERS
US9068185B2 (en) 2010-03-12 2015-06-30 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
WO2011115818A1 (en) 2010-03-17 2011-09-22 Isis Pharmaceuticals, Inc. 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
CN103037682A (zh) 2010-03-18 2013-04-10 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
DE112011100940T5 (de) 2010-03-18 2013-01-24 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
BR112012023503A2 (pt) 2010-03-19 2015-09-01 Basf Plant Science Co Gmbh Método para aumentar o rendimento em plantas em relação a plantas de controle, planta, construção, uso de uma construção, métodos para a produção de uma planta transgênica e de um produto, partes colhíveis de uma planta, produtos derivados de uma planta e uso de um ácido nucleico
AU2011228665A1 (en) 2010-03-19 2012-11-08 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
EP2371845A1 (en) 2010-03-22 2011-10-05 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
RU2610661C2 (ru) 2010-04-09 2017-02-14 Курна, Инк. Лечение заболеваний, связанных с фактором роста фибробластов 21 (fgf21), путем ингибирования природного антисмыслового транскрипта к fgf21
EP2385129A1 (en) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Enhanced methods for gene regulation in plants
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CA2797362C (en) 2010-04-27 2020-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
JP6005628B2 (ja) 2010-04-28 2016-10-12 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 修飾ヌクレオシド、その類似体、およびこれらから調製されるオリゴマー化合物
CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
EP3091027B1 (en) 2010-04-28 2018-01-17 Ionis Pharmaceuticals, Inc. 5' modified nucleosides and oligomeric compounds prepared therefrom
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
BR112012027547B1 (pt) 2010-04-29 2022-06-14 Ionis Pharmaceuticals, Inc Oligonucleotídeo modificado de fita simples, composição, e seus usos para tratar amiloidose transtirretina, reduzir os seus sintomas e para reduzir a expressão de mrna ou de proteína de transtirretina
JP2013525483A (ja) 2010-05-03 2013-06-20 カッパーアールエヌエー，インコーポレイテッド サーチュイン（ｓｉｒｔ）に対する天然アンチセンス転写物の阻害によるサーチュイン（ｓｉｒｔ）関連疾患の治療
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
EP2566893A1 (en) 2010-05-03 2013-03-13 F. Hoffmann-La Roche AG Compositions and methods for the diagnosis and treatment of tumor
CA2797277C (en) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CA2798067A1 (en) 2010-05-04 2011-11-24 Basf Se Plants having increased tolerance to herbicides
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
MX2012012672A (es) 2010-05-06 2012-12-17 Du Pont Gen y proteina acc sintasa 3 de maiz y sus usos.
GB201007834D0 (en) 2010-05-11 2010-06-23 Vib Vzw Growth promoting fusion proteins
DK2569430T3 (en) 2010-05-12 2019-02-04 Univ Columbia PROCEDURES FOR MANUFACTURING ENTEROENDOCRIN CELLS WHICH MANUFACTURE AND SECRET INSULIN
EP3023496B1 (en) 2010-05-13 2020-07-29 Sarepta Therapeutics, Inc. Compounds which modulate interleukins 17 and 23 signaling activity
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
TWI531370B (zh) 2010-05-14 2016-05-01 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
US8895528B2 (en) 2010-05-26 2014-11-25 Curna, Inc. Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
JP6046607B2 (ja) 2010-05-27 2016-12-21 エータイアー ファーマ， インコーポレイテッド グルタミニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2011156278A1 (en) 2010-06-07 2011-12-15 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
US8846637B2 (en) 2010-06-08 2014-09-30 Isis Pharmaceuticals, Inc. Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
CN103260649A (zh) 2010-06-15 2013-08-21 迈德詹尼克斯医疗以色列有限公司 长效药物制剂
CN103068992A (zh) 2010-06-24 2013-04-24 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
KR101429476B1 (ko) 2010-06-25 2014-08-22 바스프 플랜트 사이언스 컴퍼니 게엠베하 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법
CN103080320A (zh) 2010-07-01 2013-05-01 纳幕尔杜邦公司 涉及编码pae以及pae样多肽的基因并具有改变的贮藏化合物水平的植物种子、相关的构建体和的方法
WO2012004013A2 (en) 2010-07-08 2012-01-12 Bayer Bioscience N.V. Glucosinolate transporter protein and uses thereof
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EP2593547B1 (en) 2010-07-14 2017-11-15 CuRNA, Inc. Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
DE112011102378T5 (de) 2010-07-16 2013-04-18 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
UA112969C2 (uk) 2010-08-03 2016-11-25 Сібас Юс Ллс Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
US20120122223A1 (en) 2010-08-03 2012-05-17 Cibus Us Llc Mutated protoporphyrinogen ix oxidase (ppx) genes
US9187762B2 (en) 2010-08-13 2015-11-17 Pioneer Hi-Bred International, Inc. Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (HPPD) activity
BR112013004183A2 (pt) 2010-08-24 2016-05-10 Basf Plant Science Co Gmbh plantas com melhores características relacionadas ao rendimento e método para sua produção
EP2608801B1 (en) 2010-08-25 2019-08-21 aTyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
WO2012028673A1 (en) 2010-09-02 2012-03-08 Ludwig-Maximilians-Universitaet Muenchen Spontaneous organogenesis in plants
EP2426204A1 (en) 2010-09-02 2012-03-07 Ludwig-Maximilians-Universität München Spontaneous nodule organogenesis in plants
WO2012047968A2 (en) 2010-10-05 2012-04-12 Genentech, Inc. Mutant smoothened and methods of using the same
CN103210086B (zh) 2010-10-06 2017-06-09 库尔纳公司 通过抑制唾液酸酶4(neu4)的天然反义转录物而治疗neu4相关疾病
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
CN103180445B (zh) 2010-10-22 2018-02-16 库尔纳公司 通过抑制α‑L‑艾杜糖醛酸酶(IDUA)的天然反义转录物而治疗IDUA相关疾病
CN103201387B (zh) 2010-10-27 2018-02-02 库尔纳公司 通过抑制干扰素相关发育调节因子1(ifrd1)的天然反义转录物而治疗ifrd1相关疾病
CN103298943A (zh) 2010-11-10 2013-09-11 巴斯夫植物科学有限公司 产量相关性状增强的植物及其制备方法
AU2011325956B2 (en) 2010-11-12 2016-07-14 The General Hospital Corporation Polycomb-associated non-coding RNAs
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
WO2012068405A2 (en) 2010-11-17 2012-05-24 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
JP6071893B2 (ja) 2010-11-23 2017-02-01 カッパーアールエヌエー，インコーポレイテッド Ｎａｎｏｇへの天然アンチセンス転写物の阻害によるｎａｎｏｇ関連疾患の治療
CA2818913C (en) 2010-12-06 2020-12-15 Basf Plant Science Company Gmbh Methods for the production of synthetic promoters with defined specificity
JP6334169B2 (ja) 2010-12-16 2018-05-30 ビーエーエスエフ アグロ ベー．ブイ． 除草剤耐性の増大した植物
CA2823467C (en) 2010-12-22 2020-10-27 Pioneer Hi-Bred International, Inc. Qtls associated with and methods for identifying whole plant field resistance to sclerotinia
US9045749B2 (en) 2011-01-14 2015-06-02 The General Hospital Corporation Methods targeting miR-128 for regulating cholesterol/lipid metabolism
WO2012098517A1 (en) 2011-01-20 2012-07-26 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
WO2012101599A2 (en) 2011-01-27 2012-08-02 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US9688719B2 (en) 2011-01-27 2017-06-27 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
UA123491C2 (uk) 2011-02-01 2021-04-14 Колорадо Уіт Рісерч Фаундейшн, Інк. РОСЛИНА, СТІЙКА ДО КВІЗАЛОФОП-р-ЕТИЛУ, ТА СПОСІБ ЇЇ ОДЕРЖАННЯ
US20130338178A1 (en) 2011-02-02 2013-12-19 The Trustees Of Princeton University Sirtuin modulators as inhibitors of cytomegalovirus
TWI593416B (zh) 2011-02-02 2017-08-01 艾克厘德製藥公司 利用針對結締組織生長因子（ｃｔｇｆ）目標之反義化合物治療瘢痕或肥厚性疤痕之方法
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
AR085394A1 (es) 2011-02-25 2013-09-25 Univ Nac De La Plata Unlp Proteasa de plantas
WO2012117330A1 (en) 2011-02-28 2012-09-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and producing methods thereof
EP2681323A4 (en) 2011-02-28 2015-03-18 Basf Plant Science Co Gmbh PLANTS WITH IMPROVED EFFICIENCY AND MANUFACTURING METHOD THEREFOR
BR112013022227A2 (pt) 2011-03-01 2017-09-19 Basf Plant Science Co Gmbh plantas possuindo características relacionadas ao rendimento melhoradas e métodos de produção das mesmas
JP6031510B2 (ja) 2011-04-12 2016-11-24 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
CA2833876A1 (en) 2011-04-29 2012-11-01 Pioneer Hi-Bred International, Inc. Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
CA2834183A1 (en) 2011-05-19 2012-11-22 Enrique ROJO DE LA VIESCA Process for modifying the architecture and improving the yield of crop plants
CN103620036B (zh) 2011-06-09 2016-12-21 库尔纳公司 通过抑制共济蛋白(fxn)的天然反义转录物而治疗fxn 相关疾病
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
US20140216118A1 (en) 2011-06-14 2014-08-07 Synthon Biopharmaceuticals B.V. Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic Plants
AR087167A1 (es) 2011-07-12 2014-02-26 Two Blades Foundation Genes de resistencia al tizon tardio
WO2013012643A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
US9556449B2 (en) 2011-07-15 2017-01-31 Syngenta Participations Ag Methods of increasing yield and stress tolerance in a plant by decreasing the activity of a trehalose-6-phosphate phosphatase
EP2739737A4 (en) 2011-08-01 2015-08-26 Basf Plant Science Co Gmbh METHOD OF IDENTIFYING AND INSULATING CLOSURE SEQUENCES FOR IMPROVED TRANSCRIPTION
AU2012308320C1 (en) 2011-09-14 2018-08-23 Translate Bio Ma, Inc. Multimeric oligonucleotide compounds
WO2013040499A1 (en) 2011-09-14 2013-03-21 Northwestern University Nanoconjugates able to cross the blood-brain barrier
MX2014004516A (es) 2011-10-11 2015-01-16 Brigham & Womens Hospital Micro-arns en trastornos neurodegenerativos.
CA2853449A1 (en) 2011-10-25 2013-05-02 Pioneer Hi-Bred International, Inc. Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
EP2773762A1 (en) 2011-10-31 2014-09-10 Pioneer Hi-Bred International Inc. Improving plant drought tolerance, nitrogen use efficiency and yield
DK2790736T3 (en) 2011-12-12 2018-05-07 Oncoimmunin Inc In vivo delivery of oligonucleotides
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
EP2825551A1 (en) 2012-03-13 2015-01-21 Pioneer Hi-Bred International Inc. Genetic reduction of male fertility in plants
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
TR201815503T4 (tr) 2012-03-15 2018-11-21 Curna Inc Beyin kaynaklı nörotrofik faktör (bknf) ile ilişkili hastalıkların doğal antisens transkriptinin bknf'ye inhibisyonu ile muamelesi.
CA2907072A1 (en) 2012-03-16 2013-09-19 Valerion Therapeutics, Llc Antisense conjugates for decreasing expression of dmpk
US9221864B2 (en) 2012-04-09 2015-12-29 Isis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
CN104704122A (zh) 2012-04-20 2015-06-10 艾珀特玛治疗公司 产热的miRNA调节剂
WO2013163628A2 (en) 2012-04-27 2013-10-31 Duke University Genetic correction of mutated genes
KR102028784B1 (ko) 2012-05-16 2019-10-04 트랜슬레이트 바이오 인코포레이티드 유전자 발현을 조절하기 위한 조성물 및 방법
EA201492123A1 (ru) 2012-05-16 2015-10-30 Рана Терапьютикс, Инк. Композиции и способы для модулирования экспрессии семейства генов smn
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
WO2013184209A1 (en) 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder
AR091489A1 (es) 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
EP2677035A1 (en) 2012-06-22 2013-12-25 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US20150216892A1 (en) 2012-08-03 2015-08-06 Aptamir Therapeutics, Inc. Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
KR102237882B1 (ko) 2012-08-15 2021-04-07 아이오니스 파마수티컬즈, 인코포레이티드 변형된 캡핑 프로토콜을 이용하는 올리고머 화합물 제조 방법
EP2885411B1 (en) 2012-08-16 2018-12-05 VIB vzw Means and methods for altering the lignin pathway in plants
WO2014037735A1 (en) 2012-09-10 2014-03-13 University Of Leicester Atsp1, an e3 ubiquitin ligase, and its use
US9029335B2 (en) 2012-10-16 2015-05-12 Isis Pharmaceuticals, Inc. Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
CN105473720A (zh) 2012-11-20 2016-04-06 先锋国际良种公司 用于高效摄取和利用尿素以提高作物产量的工程改造植物
CN105008541A (zh) 2012-12-21 2015-10-28 先锋国际良种公司 用于生长素类似物缀合的组合物和方法
EP2754715A1 (en) 2013-01-11 2014-07-16 Consejo Superior De Investigaciones Científicas (CSIC) Stress tolerant plants
US10462994B2 (en) 2013-01-29 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP7
US10231397B2 (en) 2013-01-29 2019-03-19 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
CN104994725B (zh) 2013-01-29 2022-07-01 巴斯夫植物科学有限公司 表达hcp6的抗真菌植物
WO2014121436A1 (en) 2013-02-05 2014-08-14 Plant Bioscience Limited Transgenic plants
BR112015021857B1 (pt) 2013-03-08 2022-05-10 Basf Plant Science Company Gmbh Método para aumentar a resistência à ferrugem da soja em uma planta de soja que expressa proteína mybtf e método para a produção de uma planta de soja transgênica que expressa proteína mybtf
US20160002648A1 (en) 2013-03-11 2016-01-07 Mei Guo Genes for improving nutrient uptake and abiotic stress tolerance in plants
US10329574B2 (en) 2013-03-12 2019-06-25 E I Du Pont De Nemours And Company Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
US20160017360A1 (en) 2013-03-13 2016-01-21 Pioneer Hi-Bred International, Inc. Functional expression of bacterial major facilitator superfamily mfs gene in maize to improve agronomic traits and grain yield
WO2014164074A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Enhanced nitrate uptake and nitrate translocation by over-expressing maize functional low-affinity nitrate transporters in transgenic maize
EA037142B1 (ru) 2013-03-14 2021-02-10 Сибас Юс Ллс Мутированные гены алленоксидсинтазы 2 (aos2)
US20140304857A1 (en) 2013-03-14 2014-10-09 Pioneer Hi Bred International Inc Maize stress related transcription factor 18 and uses thereof
BR112015022848B1 (pt) 2013-03-15 2022-10-11 Cibus Europe B.V. Método para introdução de uma mutação mediada por gron em uma sequência de dna alvo em um protoplasto vegetal e uso de uma ou mais endonucleases sítio específica que introduzem cortes de fita única
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
WO2014152507A2 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Modulation of acc deaminase expression
MY183741A (en) 2013-03-15 2021-03-10 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
CN105143454A (zh) 2013-03-15 2015-12-09 先锋国际良种公司 Acc氧化酶多核苷酸和多肽的组合物和使用方法
WO2014147249A1 (en) 2013-03-21 2014-09-25 Vib Vzw Means and methods for the reduction of photorespiration in crops
AU2014259759B2 (en) 2013-05-01 2020-06-18 Ionis Pharmaceuticals, Inc. Compositions and methods
DK3007704T3 (da) 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali
EP2816115A1 (en) 2013-06-17 2014-12-24 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
EP3013850B1 (en) 2013-06-24 2018-07-25 Ramot at Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US11459579B2 (en) 2013-07-09 2022-10-04 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
US10570409B2 (en) 2013-07-09 2020-02-25 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2844640A1 (en) 2013-12-06 2015-06-06 The University Of British Columbia Method for treatment of castration-resistant prostate cancer
EP2896698A1 (en) 2014-01-17 2015-07-22 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
WO2015116680A1 (en) 2014-01-30 2015-08-06 Two Blades Foundation Plants with enhanced resistance to phytophthora
WO2015117010A2 (en) 2014-01-31 2015-08-06 Temple University Of The Commonwealth System Of Higher Education Bag3 as a target for therapy of heart failure
JP6736467B2 (ja) 2014-02-04 2020-08-05 ジェネンテック， インコーポレイテッド 平滑化変異体及びその使用方法
EA201691581A1 (ru) 2014-03-14 2017-02-28 Кибус Юс Ллс Способы и композиции для повышения эффективности направленной модификации генов с применением опосредованной олигонуклеотидами репарации генов
EP3119789B1 (en) 2014-03-17 2020-04-22 Ionis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
US10006027B2 (en) 2014-03-19 2018-06-26 Ionis Pharmaceuticals, Inc. Methods for modulating Ataxin 2 expression
IL247600B (en) 2014-03-19 2022-06-01 Ionis Pharmaceuticals Inc Preparations for the modulation of ataxin 2 expression
SI3126499T1 (sl) 2014-04-01 2020-09-30 Biogen Ma Inc. Sestave za moduliranje izražanja SOD-1
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
WO2015164693A1 (en) 2014-04-24 2015-10-29 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
RU2701645C2 (ru) 2014-05-01 2019-09-30 Ионис Фармасьютикалз, Инк. Композиции и способы модулирования экспрессии фактора комплемента в
WO2015171603A1 (en) 2014-05-06 2015-11-12 Two Blades Foundation Methods for producing plants with enhanced resistance to oomycete pathogens
PL3164113T3 (pl) 2014-06-04 2019-09-30 Exicure, Inc. Wielowartościowe dostarczanie modulatorów immunologicznych w liposomowych kolistych kwasach nukleinowych do zastosowań profilaktycznych lub terapeutycznych
EP4039807A1 (en) 2014-06-10 2022-08-10 Erasmus University Rotterdam Medical Center Antisense oligonucleotides useful in treatment of pompe disease
WO2015200697A1 (en) 2014-06-25 2015-12-30 The General Hospital Corporation Targeting human satellite ii (hsatii)
CA2985344A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
WO2016005449A1 (en) 2014-07-08 2016-01-14 Vib Vzw Means and methods to increase plant yield
PT3169778T (pt) 2014-07-14 2024-01-29 Univ Washington State Knock-out de nanos que conduz à ablação de células da linha germinativa
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
WO2016049512A1 (en) 2014-09-26 2016-03-31 University Of Massachusetts Rna-modulating agents
WO2016057515A2 (en) 2014-10-06 2016-04-14 Altria Client Services Llc Genetic control of axillary bud growth in tobacco plants
SG11201703939XA (en) 2014-11-17 2017-06-29 Moerae Matrix Inc Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
CA2968531A1 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
CA2971425A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
US9688707B2 (en) 2014-12-30 2017-06-27 Ionis Pharmaceuticals, Inc. Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
US10793855B2 (en) 2015-01-06 2020-10-06 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
WO2016115490A1 (en) 2015-01-16 2016-07-21 Ionis Pharmaceuticals, Inc. Compounds and methods for modulation of dux4
CR20170382A (es) 2015-01-21 2018-02-16 Basf Se Plantas que tienen una mayor tolerancia a herbicidas
CN108012523A (zh) 2015-02-03 2018-05-08 中国科学院遗传与发育生物学研究所 具有增加的种子大小的植物
US10485196B2 (en) 2015-02-03 2019-11-26 The Institute Of Genetics And Developmental Biology Chinese Academy Of Scinces Rice plants with altered seed phenotype and quality
BR112017016688B1 (pt) 2015-02-04 2024-01-23 Basf Plant Science Company Gmbh Método para aumentar a resistência fúngica, método para a produção de um produto e método para criar uma planta resistente a fungos
GB201501941D0 (en) 2015-02-05 2015-03-25 British American Tobacco Co Method
WO2016130600A2 (en) 2015-02-09 2016-08-18 Duke University Compositions and methods for epigenome editing
AR103649A1 (es) 2015-02-11 2017-05-24 Basf Se Hidroxifenilpiruvato dioxigenasas resistentes a herbicidas
GB201502409D0 (en) 2015-02-13 2015-04-01 British American Tobacco Co Method
US11129844B2 (en) 2015-03-03 2021-09-28 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating MECP2 expression
US9999655B2 (en) 2015-03-12 2018-06-19 Moerae Matrix, Inc. Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
EP3271467A1 (en) 2015-03-18 2018-01-24 Basf Se Recombinant microorganism for improved production of fine chemicals
US10961532B2 (en) 2015-04-07 2021-03-30 The General Hospital Corporation Methods for reactivating genes on the inactive X chromosome
US10407678B2 (en) 2015-04-16 2019-09-10 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
US11697820B2 (en) 2015-05-09 2023-07-11 Two Blades Foundation Late blight resistance gene from Solanum americanum and methods of use
BR112017025923A2 (pt) 2015-06-04 2018-08-14 Basf Se molécula de ácido nucleico recombinante, molécula de aminoácido recombinante, construto de expressão recombinante, vetor recombinante, micro-organismo recombinante, composição, métodos para produção de um micro-organismo recombinante e para cultivo e crescimento de um micro-organismo geneticamente modificado, uso de uma molécula de ácido nucleico recombinante, e, processo para produção fermentativa de um composto.
EP3307902A1 (en) 2015-06-12 2018-04-18 Basf Se Recombinant microorganism for improved production of alanine
WO2016210241A1 (en) 2015-06-26 2016-12-29 Beth Israel Deaconess Medical Center, Inc. Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells
EP3314027A4 (en) 2015-06-29 2019-07-03 Caris Science, Inc. THERAPEUTIC OLIGONUCLEOTIDES
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
EP3353303B1 (en) 2015-09-25 2023-08-02 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating ataxin 3 expression
WO2017062790A1 (en) 2015-10-09 2017-04-13 Two Blades Foundation Cold shock protein receptors and methods of use
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
CA3007424A1 (en) 2015-11-05 2017-05-11 Children's Hospital Los Angeles "mobilizing leukemia cells"
WO2017087708A1 (en) 2015-11-19 2017-05-26 The Brigham And Women's Hospital, Inc. Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
EP3389670A4 (en) 2015-12-04 2020-01-08 Ionis Pharmaceuticals, Inc. METHODS OF TREATING BREAST CANCER
WO2017099579A1 (en) 2015-12-07 2017-06-15 Erasmus University Medical Center Rotterdam Enzymatic replacement therapy and antisense therapy for pompe disease
WO2017120365A1 (en) 2016-01-05 2017-07-13 Ionis Pharmaceuticals, Inc. Methods for reducing lrrk2 expression
CA3019952A1 (en) 2016-02-04 2017-08-10 Curis, Inc. Mutant smoothened and methods of using the same
US11542515B2 (en) 2016-02-09 2023-01-03 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
JP7033072B2 (ja) 2016-02-25 2022-03-09 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド Ｓｍｏｃ２を標的化する線維症のための治療方法
CN109715810B (zh) 2016-03-11 2023-07-14 奥驰亚客户服务有限公司 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法
EP3429690A4 (en) 2016-03-16 2019-10-23 Ionis Pharmaceuticals, Inc. METHOD FOR MODULATING KEAP1
US10577607B2 (en) 2016-03-16 2020-03-03 Ionis Pharmaceuticals, Inc. Modulation of DYRK1B expression
US10731166B2 (en) 2016-03-18 2020-08-04 Caris Science, Inc. Oligonucleotide probes and uses thereof
HUE056865T2 (hu) 2016-03-30 2022-03-28 Basf Se N-Butil-akrilát fermentatív elõállítása alkohol-acil-transzferáz enzim segítségével
US10563216B2 (en) 2016-04-18 2020-02-18 Bloomsburg University of Pennsylvania Compositions and methods of delivering molecules to plants
EP4166661A1 (en) 2016-04-29 2023-04-19 BASF Plant Science Company GmbH Fused donor - guide nucleic acid and methods for modification of target nucleic acids
EP3054014A3 (en) 2016-05-10 2016-11-23 BASF Plant Science Company GmbH Use of a fungicide on transgenic plants
US11959086B2 (en) 2016-05-20 2024-04-16 BASF Agro B.V. Dual transit peptides for targeting polypeptides
CA3025047A1 (en) 2016-05-24 2017-11-30 Basf Se Method for controlling ppo resistant weeds
US11293017B2 (en) 2016-05-25 2022-04-05 Caris Science, Inc. Oligonucleotide probes and uses thereof
WO2017202715A1 (en) 2016-05-26 2017-11-30 Nunhems B.V. Seedless fruit producing plants
AU2017286811A1 (en) 2016-06-17 2018-11-22 Ionis Pharmaceuticals, Inc. Modulation of gys1 expression
BR112018076811A2 (pt) 2016-06-22 2019-08-27 Univ North Carolina State métodos, usos, construção ou vetor, célula, planta, material de propagação de planta, folha colhida, folha processada, produto de planta, produto de tabaco, extrato de planta e artigo de fumar
EP3481430A4 (en) 2016-07-11 2020-04-01 Translate Bio Ma, Inc. NUCLEIC ACID CONJUGATES AND USES THEREOF
EP3484278A4 (en) 2016-07-15 2020-02-19 Basf Se PLANTS WITH INCREASED TOLERANCE FOR HERBICIDES
US11149030B2 (en) 2016-07-27 2021-10-19 BASF Agro B.V. Plants having increased tolerance to herbicides
WO2018019842A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018024696A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
US20210352900A1 (en) 2016-08-05 2021-11-18 Basf Se Method for Controlling PPO Resistant Weeds
NL2017295B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Antisense oligomeric compound for Pompe disease
EP3278667A1 (en) 2016-08-05 2018-02-07 Basf Se Method for controlling ppo-inhibitor resistant weeds
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
CA3032238A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281523A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
EP3281524A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
US11193136B2 (en) 2016-08-09 2021-12-07 Vib Vzw Cellulose synthase inhibitors and mutant plants
BR112019001934B1 (pt) 2016-08-09 2022-09-20 Basf Se Método para controlar o crescimento de ervas daninhas, uso de compostos de fórmula (i) e uso da composição
EP3281525A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
WO2018029031A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
KR20190065341A (ko) 2016-10-06 2019-06-11 아이오니스 파마수티컬즈, 인코포레이티드 올리고머 화합물들의 접합 방법
WO2018067985A1 (en) 2016-10-07 2018-04-12 Altria Client Services Llc Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (tsnas)
EP3532638A4 (en) 2016-10-31 2020-07-29 University of Massachusetts TARGETING MICROARN-101-3 P IN CARCINOTHERAPY
JOP20190104A1 (ar) 2016-11-10 2019-05-07 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن atxn3
EP3548620A4 (en) 2016-12-02 2020-07-22 Cold Spring Harbor Laboratory MODULATION OF THE EXPRESSION OF LNC05
WO2018112356A1 (en) 2016-12-16 2018-06-21 Two Blades Foundation Late blight resistance genes and methods of use
CN110382702A (zh) 2016-12-20 2019-10-25 巴斯夫农业公司 具有增加的除草剂耐性的植物
RU2019117393A (ru) 2016-12-27 2020-12-07 Инбиоз Н.В. Синтез сиалированных соединений in vivo
WO2018140214A1 (en) 2017-01-24 2018-08-02 Pioneer Hi-Bred International, Inc. Nematicidal protein from pseudomonas
CN110573623A (zh) 2017-02-09 2019-12-13 福建农林大学 用于提高植物产量的磷酸盐转运蛋白的表达
US11180756B2 (en) 2017-03-09 2021-11-23 Ionis Pharmaceuticals Morpholino modified oligomeric compounds
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
EP3612232A1 (en) 2017-04-21 2020-02-26 The Broad Institute, Inc. Targeted delivery to beta cells
US11445692B2 (en) 2017-05-15 2022-09-20 Equi-Nom Ltd. Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof
WO2019023587A1 (en) 2017-07-28 2019-01-31 Two Blades Foundation POTYVIRUS RESISTANCE GENES AND METHODS OF USE
EP3668984A4 (en) 2017-08-18 2021-09-08 Ionis Pharmaceuticals, Inc. MODULATION OF THE NOTCH SIGNALING PATH FOR THE TREATMENT OF RESPIRATORY DISORDERS
US10517889B2 (en) 2017-09-08 2019-12-31 Ionis Pharmaceuticals, Inc. Modulators of SMAD7 expression
CN111108205B (zh) 2017-09-11 2024-05-28 奥驰亚客户服务有限公司 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019108619A1 (en) 2017-11-28 2019-06-06 Two Blades Foundation Methods and compositions for enhancing the disease resistance of plants
CN111801012A (zh) 2017-11-29 2020-10-20 巴斯夫欧洲公司 具有增加的除草剂耐受性的植物
US11634698B2 (en) 2017-12-20 2023-04-25 Basf Se Nucleases and methods for making and using them
WO2019126641A2 (en) 2017-12-21 2019-06-27 Ionis Pharmaceuticals, Inc. Modulation of frataxin expression
US11034969B2 (en) 2017-12-22 2021-06-15 Altria Client Services Llc Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter
CN107868123B (zh) 2017-12-25 2020-05-12 中国农业科学院作物科学研究所 一种同时提高植物产量和抗性的基因及其应用
CA3087266A1 (en) 2018-01-09 2019-07-18 Cibus Us Llc Shatterproof genes and mutations
EP3737226A1 (en) 2018-01-12 2020-11-18 Two Blades Foundation Stem rust resistance genes and methods of use
PE20211242A1 (es) 2018-01-15 2021-07-09 Ionis Pharmaceuticals Inc Moduladores de la expresion dnm2
MX2020007682A (es) 2018-01-17 2020-09-14 Basf Se Plantas que tienen una mayor tolerancia a herbicidas.
CN111818794A (zh) 2018-02-14 2020-10-23 中国科学院遗传与发育生物学研究所 增加营养物利用效率的方法
US11732260B2 (en) 2018-03-02 2023-08-22 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of amyloid-β precursor protein
AU2019228607B2 (en) 2018-03-02 2024-03-07 Ionis Pharmaceuticals, Inc. Modulators of IRF4 expression
US11661601B2 (en) 2018-03-22 2023-05-30 Ionis Pharmaceuticals, Inc. Methods for modulating FMR1 expression
WO2019186514A2 (en) 2018-03-30 2019-10-03 Rheinische Friedrich-Wilhelms-Universitat Bonn Aptamers for targeted activaton of t cell-mediated immunity
US11377665B2 (en) 2018-04-03 2022-07-05 Altria Client Services Llc Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (TSNAs)
AU2019247490A1 (en) 2018-04-06 2020-10-22 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
CN112041440A (zh) 2018-04-11 2020-12-04 Ionis制药公司 Ezh2表达的调节剂
WO2019206994A1 (en) 2018-04-26 2019-10-31 Basf Se Lipase enzymes
WO2019211143A1 (en) 2018-05-03 2019-11-07 Basf Se Amylase enzymes
JOP20200280A1 (ar) 2018-05-09 2020-11-05 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير الوراثي عن fxi
MX2020011911A (es) 2018-05-09 2021-01-29 Ionis Pharmaceuticals Inc Compuestos y metodos para reducir de la expresion de atxn3.
WO2019219933A1 (en) 2018-05-17 2019-11-21 Vib Vzw An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids
AU2019287635A1 (en) 2018-06-14 2020-12-17 Ionis Pharmaceuticals, Inc. Compounds and methods for increasing STMN2 expression
US11291176B2 (en) 2018-06-15 2022-04-05 Nunhems B.V. Seedless watermelon plants comprising modifications in an ABC transporter gene
UY38282A (es) 2018-06-27 2019-12-31 Ionis Pharmaceuticals Inc Compuestos y métodos para la reducción de la expresión de lrrk2
EP3817747A4 (en) 2018-07-02 2022-07-06 Aptamir Therapeutics, Inc. TARGETED DELIVERY OF THERAPEUTIC AGENTS TO HUMAN ADIPOCYTES
AU2019310097A1 (en) 2018-07-25 2021-02-04 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing ATXN2 expression
US20210292766A1 (en) 2018-08-29 2021-09-23 University Of Massachusetts Inhibition of Protein Kinases to Treat Friedreich Ataxia
CA3110656A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
AU2019334672A1 (en) 2018-09-07 2021-03-25 Basf Plant Science Company Gmbh Improved method for the production of high levels of PUFA in plants
US20230183728A1 (en) 2018-09-07 2023-06-15 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
MX2021004433A (es) 2018-10-18 2021-07-06 Basf Se Metodo para la produccion de acido acrilico o sus sales.
TW202028222A (zh) 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑
JP2022509059A (ja) 2018-11-15 2022-01-20 アイオーニス ファーマシューティカルズ， インコーポレーテッド Ｉｒｆ５発現の調節因子
CA3124395A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
CN113614242A (zh) 2019-01-22 2021-11-05 巴斯夫欧洲公司 4-氰基苯甲酸或其盐的生产方法
EP3914069A1 (en) 2019-01-24 2021-12-01 Altria Client Services LLC Tobacco plants comprising reduced nicotine and reduced tobacco specific nitrosamines
US11214803B2 (en) 2019-01-31 2022-01-04 Ionis Pharmaceuticals, Inc. Modulators of YAP1 expression
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
GB201902253D0 (en) 2019-02-19 2019-04-03 Univ Court Univ Of Glasgow Methods for optogenetic manipulation of stomatal function
MX2021010152A (es) 2019-02-27 2021-09-14 Ionis Pharmaceuticals Inc Moduladores de la expresion de malat1.
US20220186200A1 (en) 2019-03-11 2022-06-16 Basf Se Amylases and methods for making and using them
WO2020183191A1 (en) 2019-03-14 2020-09-17 Rothamsted Research Limited Genetically modified plants with enhanced drought tolerance
EP3947664A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
EP3947665A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
JOP20210261A1 (ar) 2019-03-29 2023-01-30 Ionis Pharmaceuticals Inc مركبات وطرق لتعديل ube3a-ats
US20220220495A1 (en) 2019-05-10 2022-07-14 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2020260104A1 (en) 2019-06-27 2020-12-30 Basf Plant Science Company Gmbh Methods for transformation of fungal spores
WO2020264237A1 (en) 2019-06-27 2020-12-30 Two Blades Foundation Engineered atrlp23 pattern recognition receptors and methods of use
WO2021011348A1 (en) 2019-07-12 2021-01-21 The Regents Of The University Of California Plants with enhanced resistance to bacterial pathogens
EP3956450A4 (en) 2019-07-26 2022-11-16 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATION OF GFAP
JP2022544587A (ja) 2019-08-15 2022-10-19 アイオーニス ファーマシューティカルズ， インコーポレーテッド 結合修飾オリゴマー化合物及びその使用
BR112022000573A2 (pt) 2019-08-22 2022-03-15 Basf Se Polipeptídeo isolado, sintético ou recombinante com atividade alfa-amilase, ácido nucleico isolado, sintético ou recombinante, construto de ácido nucleico, vetor de expressão, célula hospedeira, composição, método para produzir polipeptídeo isolado, sintético ou recombinante, método para preparar uma massa ou um produto de panificação, e, métodos para usar o polipeptídeo isolado, sintético ou recombinante e um domínio c de uma primeira amilase
CA3150334A1 (en) 2019-09-12 2021-03-18 Frank Meulewaeter REGULATORY NUCLEIC ACID MOLECULES TO ENHANCE GENE EXPRESSION IN PLANTS
WO2021058691A1 (en) 2019-09-26 2021-04-01 Basf Se Method for the production of beta-alanine or salts thereof
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
AU2020396138A1 (en) 2019-12-03 2022-06-16 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
US20230075913A1 (en) 2019-12-16 2023-03-09 BASF Agricultural Solutions Seed US LLC Codon-optimized cas9 endonuclease encoding polynucleotide
WO2021122081A1 (en) 2019-12-16 2021-06-24 Basf Se Precise introduction of dna or mutations into the genome of wheat
WO2021122080A1 (en) 2019-12-16 2021-06-24 BASF Agricultural Solutions Seed US LLC Improved genome editing using paired nickases
BR112022016238A2 (pt) 2020-02-28 2022-10-11 Ionis Pharmaceuticals Inc Compostos e métodos para modular smn2
CN115176018A (zh) 2020-03-04 2022-10-11 巴斯夫欧洲公司 用于大肠杆菌和芽孢杆菌中表达的穿梭载体
CN115605597A (zh) 2020-03-04 2023-01-13 巴斯夫欧洲公司（De） 用于产生赋予低至中等表达的组成型细菌启动子的方法
JP2023524065A (ja) 2020-05-01 2023-06-08 アイオーニス ファーマシューティカルズ， インコーポレーテッド Ａｔｘｎ１を調節するための化合物及び方法
US20230383321A1 (en) 2020-05-15 2023-11-30 Basf Se Improved method for the production of isoprenoids
KR20230029837A (ko) 2020-06-29 2023-03-03 아이오니스 파마수티컬즈, 인코포레이티드 Plp1을 조절하기 위한 화합물 및 방법
US11730133B2 (en) 2020-10-21 2023-08-22 Equi-Nom Ltd High yield sesame
TW202227101A (zh) 2020-11-18 2022-07-16 美商Ionis製藥公司 用於調節血管收縮素原表現之化合物及方法
JP2024518825A (ja) 2021-05-11 2024-05-07 トゥー・ブレーズ・ファウンデーション 疾病耐性に関する機能検査のための植物疾病耐性遺伝子のライブラリーを調製する方法
EP4355759A1 (en) 2021-06-18 2024-04-24 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing ifnar1 expression
CN118019447A (zh) 2021-08-06 2024-05-10 Kws蔬菜有限责任公司 菠菜对霜霉病的持久抗性
AU2022340861A1 (en) 2021-09-03 2024-03-14 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
US11395470B1 (en) 2021-09-14 2022-07-26 Equi-Nom Ltd. Sesame with high oil content and/or high yield
WO2023043220A1 (ko) 2021-09-16 2023-03-23 주식회사 큐마인 Wfdc2의 발현을 조절하는 안티센스 화합물
CA3233676A1 (en) 2021-09-30 2023-04-06 The Sainsbury Laboratory Plant disease resistance genes against stem rust and methods of use
WO2023067192A1 (en) 2021-10-21 2023-04-27 Consejo Superior De Investigaciones Cientificas (Csic) Methods for improving abiotic stress resistance
WO2023105244A1 (en) 2021-12-10 2023-06-15 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
WO2023118136A1 (en) 2021-12-22 2023-06-29 BASF Agricultural Solutions Seed US LLC Improved screening method for genome edited events
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
WO2024044352A1 (en) 2022-08-26 2024-02-29 The General Hospital Corporation Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure
WO2024083579A1 (en) 2022-10-20 2024-04-25 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2024089011A1 (en) 2022-10-26 2024-05-02 BASF Agricultural Solutions Seed US LLC Excision of recombinant dna from the genome of plant cells
WO2024094678A2 (en) 2022-11-02 2024-05-10 Basf Se Improved method for the production of natural vanillin
WO2024098002A1 (en) 2022-11-04 2024-05-10 Regeneron Pharmaceuticals, Inc. Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
WO2024107765A2 (en) 2022-11-14 2024-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1993022443A1 (en) * 1992-04-24 1993-11-11 Sri International In vivo homologous sequence targeting in eukaryotic cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503151A (en) * 1980-12-10 1985-03-05 Research Corporation Recombinant cDNA construction method and hybrid nucleotides useful in cloning
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
EP0260032B1 (en) * 1986-09-08 1994-01-26 Ajinomoto Co., Inc. Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
CA2128862C (en) * 1992-02-11 2008-05-20 Jonathan G. Seidman Homogenotization of gene-targeting events
EP0656747A4 (en) * 1992-08-21 1997-05-07 Univ California COMPOSITION AND METHOD FOR CHANGING DNA SEQUENCES BY HOMOLOGOUS RECOMBINATION.
AU6527094A (en) * 1993-03-31 1994-10-24 Hybridon, Inc. Modified oligonucleotides having improved anti-influenza activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1993022443A1 (en) * 1992-04-24 1993-11-11 Sri International In vivo homologous sequence targeting in eukaryotic cells

Also Published As

Publication number Publication date
GR3034988T3 (en) 2001-03-30
CN1142829A (zh) 1997-02-12
JP3585238B2 (ja) 2004-11-04
AU1399595A (en) 1995-06-27
US5871984A (en) 1999-02-16
DK0733059T3 (da) 2000-10-16
CN1048254C (zh) 2000-01-12
US5565350A (en) 1996-10-15
US5756325A (en) 1998-05-26
ATE196311T1 (de) 2000-09-15
DE69425903D1 (de) 2000-10-19
WO1995015972A1 (en) 1995-06-15
CN1215755A (zh) 1999-05-05
ES2149962T3 (es) 2000-11-16
DE733059T1 (de) 1997-08-28
EP0733059B1 (en) 2000-09-13
JPH09506511A (ja) 1997-06-30
AU691550B2 (en) 1998-05-21
CA2178729A1 (en) 1995-06-15
PT733059E (pt) 2001-03-30
KR100386337B1 (ko) 2004-03-24
DE69425903T2 (de) 2001-02-15
EP0733059A4 (en) 1997-05-21
KR960706500A (ko) 1996-12-09
EP0733059A1 (en) 1996-09-25
NZ278490A (en) 1998-03-25

Similar Documents

Publication Publication Date Title
CN1117866C (zh) 将预定改变引入有核细胞基因组的靶序列中的方法
JP6888213B2 (ja) 簡便で高効率の遺伝子改変非ヒト哺乳動物の作製方法
CN1309717A (zh) 无细胞嵌合体制备技术和异源双螺旋突变载体的真核应用
CN1182247C (zh) 真核细胞中序列特异性dna重组
CN101297031B (zh) 在脊椎动物中作为遗传操作和分析工具的piggyBac
CN110551759B (zh) 一种提高转基因细胞重组效率的组合物及方法
JP6948718B2 (ja) ゲノム編集方法
KR20200103769A (ko) 연장된 단일 가이드 rna 및 그 용도
WO2010085699A2 (en) Mammalian piggybac transposon and methods of use
JP2019536462A (ja) 内因性および起源ＤＮＡのワンショットガイドＲＮＡ（ｏｇＲＮＡ）標的化のためのシステムおよび方法
CN1373803A (zh) 应用同源重组定向克隆和亚克隆的方法和组合物
JP6958917B2 (ja) 遺伝子ノックイン細胞の作製方法
CN106086031A (zh) 猪肌抑素基因编辑位点及其应用
CN111718933A (zh) 一种rrbp1基因敲除热带爪蛙模型的制备方法与应用
CN1262668C (zh) 转移核酸通过核被膜的细胞转运系统的用途
CN1620503A (zh) 细胞内制备单链dna
Matsuoka et al. Germline transgenesis of the ascidian Ciona intestinalis by electroporation
EP1869193B1 (en) Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
CN113817734A (zh) 一种hectd4基因敲除斑马鱼癫痫模型及其构建方法和应用
CN110938629B (zh) 特异性识别猪Wip1基因的成套sgRNA及其应用和产品
Hermanson et al. Sleeping Beauty transposon for efficient gene delivery
CN1230540C (zh) 果蝇重组相关蛋白质及其使用方法
CN113957070A (zh) 一种chd2基因敲除斑马鱼癫痫模型及其构建方法和应用
CN1234871C (zh) 一种解毒酶基因在家蚕中稳定表达系统的构建方法
CN1292827A (zh) 核酸转移载体、含有它们的组合物及其应用

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee